| 293SLAM rinderpest infection, 00hr, biol_rep1 | 13541-145H4 |
39.55 | 3.90 |
| 293SLAM rinderpest infection, 00hr, biol_rep2 | 13542-145H5 |
48.76 | 6.07 |
| 293SLAM rinderpest infection, 00hr, biol_rep3 | 13543-145H6 |
36.07 | 3.09 |
| 293SLAM rinderpest infection, 06hr, biol_rep1 | 13544-145H7 |
35.97 | 2.91 |
| 293SLAM rinderpest infection, 06hr, biol_rep2 | 13545-145H8 |
38.02 | 2.92 |
| 293SLAM rinderpest infection, 06hr, biol_rep3 | 13546-145H9 |
33.72 | 4.07 |
| 293SLAM rinderpest infection, 12hr, biol_rep1 | 13547-145I1 |
41.62 | 3.05 |
| 293SLAM rinderpest infection, 12hr, biol_rep2 | 13548-145I2 |
44.08 | 4.60 |
| 293SLAM rinderpest infection, 12hr, biol_rep3 | 13549-145I3 |
45.74 | 5.98 |
| 293SLAM rinderpest infection, 24hr, biol_rep1 | 13550-145I4 |
60.28 | 4.06 |
| 293SLAM rinderpest infection, 24hr, biol_rep2 | 13551-145I5 |
69.93 | 6.47 |
| 293SLAM rinderpest infection, 24hr, biol_rep3 | 13552-145I6 |
60.98 | 2.85 |
| ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1 | 13625-146H7 |
19.99 | 3.87 |
| ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2 | 13626-146H8 |
17.44 | 4.06 |
| ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3 | 13627-146H9 |
17.34 | 5.05 |
| ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1 | 13628-146I1 |
15.34 | 4.53 |
| ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2 | 13629-146I2 |
18.56 | 3.71 |
| ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3 | 13630-146I3 |
18.98 | 5.06 |
| ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1 | 13631-146I4 |
17.59 | 6.93 |
| ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2 | 13632-146I5 |
18.35 | 2.56 |
| ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3 | 13633-146I6 |
20.18 | 3.74 |
| ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1 | 13634-146I7 |
16.57 | 5.35 |
| ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2 | 13635-146I8 |
14.48 | 3.10 |
| ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3 | 13636-146I9 |
22.33 | 4.37 |
| ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1 | 13637-147A1 |
19.35 | 4.39 |
| ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2 | 13638-147A2 |
16.46 | 3.48 |
| ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3 | 13639-147A3 |
30.22 | 4.95 |
| ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1 | 13640-147A4 |
19.10 | 4.48 |
| ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2 | 13641-147A5 |
15.99 | 4.36 |
| ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3 | 13642-147A6 |
17.55 | 2.71 |
| ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1 | 13643-147A7 |
19.47 | 4.40 |
| ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2 | 13644-147A8 |
21.10 | 5.08 |
| ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3 | 13645-147A9 |
21.10 | 5.49 |
| ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1 | 13646-147B1 |
13.36 | 4.62 |
| ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2 | 13647-147B2 |
21.50 | 4.67 |
| ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3 | 13648-147B3 |
23.19 | 5.17 |
| ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1 | 13649-147B4 |
19.42 | 4.09 |
| ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2 | 13650-147B5 |
15.11 | 4.63 |
| ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3 | 13651-147B6 |
19.72 | 4.32 |
| ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1 | 13652-147B7 |
15.36 | 4.32 |
| ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2 | 13653-147B8 |
18.35 | 4.00 |
| ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3 | 13654-147B9 |
17.13 | 4.54 |
| ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1 | 13655-147C1 |
20.25 | 3.59 |
| ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2 | 13656-147C2 |
22.55 | 5.24 |
| ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3 | 13657-147C3 |
17.27 | 4.82 |
| ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1 | 13658-147C4 |
17.22 | 4.65 |
| ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2 | 13659-147C5 |
22.31 | 5.28 |
| ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3 | 13660-147C6 |
23.25 | 4.17 |
| ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1 | 13661-147C7 |
25.37 | 5.74 |
| ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2 | 13662-147C8 |
19.21 | 4.65 |
| ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3 | 13663-147C9 |
19.68 | 5.53 |
| ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1 | 13664-147D1 |
22.68 | 7.12 |
| ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2 | 13665-147D2 |
13.99 | 13.99 |
| ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3 | 13666-147D3 |
26.61 | 12.42 |
| ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1 | 13667-147D4 |
22.87 | 8.62 |
| ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2 | 13668-147D5 |
10.07 | 5.87 |
| ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3 | 13669-147D6 |
7.81 | 4.13 |
| ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1 | 13670-147D7 |
20.09 | 7.13 |
| ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2 | 13671-147D8 |
29.23 | 9.31 |
| ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3 | 13672-147D9 |
4.40 | 6.29 |
| ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2 | 13674-147E2 |
20.45 | 11.28 |
| ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3 | 13675-147E3 |
22.43 | 5.61 |
| ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1 | 13676-147E4 |
3.18 | 2.39 |
| ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2 | 13677-147E5 |
8.49 | 4.08 |
| ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3 | 13678-147E6 |
22.74 | 6.82 |
| ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1 | 13679-147E7 |
23.07 | 8.52 |
| ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2 | 13680-147E8 |
32.33 | 48.49 |
| ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3 | 13681-147E9 |
7.90 | 7.90 |
| ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1 | 13682-147F1 |
34.61 | 3.90 |
| ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2 | 13683-147F2 |
23.80 | 4.46 |
| ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3 | 13684-147F3 |
16.42 | 6.10 |
| ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1 | 13685-147F4 |
7.29 | 3.64 |
| ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2 | 13686-147F5 |
19.80 | 6.19 |
| ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3 | 13687-147F6 |
22.32 | 6.11 |
| Adipocyte - breast, donor1 | 11376-118A8 |
24.55 | 4.75 |
| Adipocyte - breast, donor2 | 11327-117E4 |
15.88 | 3.69 |
| Adipocyte - omental, donor1 | 11473-119C6 |
27.86 | 4.58 |
| Adipocyte - omental, donor2 | 11474-119C7 |
23.17 | 2.99 |
| Adipocyte - omental, donor3 | 11475-119C8 |
18.09 | 3.35 |
| Adipocyte - perirenal, donor1 | 11476-119C9 |
28.71 | 3.19 |
| Adipocyte - subcutaneous, donor1 | 11259-116F8 |
13.19 | 0.00 |
| Adipocyte - subcutaneous, donor2 | 11336-117F4 |
15.81 | 4.97 |
| Adipocyte - subcutaneous, donor3 | 11408-118E4 |
15.29 | 2.61 |
| Adipocyte differentiation, day04, donor1 | 13019-139D4 |
20.73 | 3.72 |
| Adipocyte differentiation, day04, donor2 | 13022-139D7 |
20.85 | 5.15 |
| Adipocyte differentiation, day04, donor3 | 13025-139E1 |
25.65 | 3.07 |
| Adipocyte differentiation, day04, donor4 | 13028-139E4 |
21.75 | 4.11 |
| Adipocyte differentiation, day08, donor1 | 13020-139D5 |
15.76 | 3.78 |
| Adipocyte differentiation, day08, donor2 | 13023-139D8 |
17.75 | 1.61 |
| Adipocyte differentiation, day08, donor3 | 13026-139E2 |
10.13 | 3.20 |
| Adipocyte differentiation, day08, donor4 | 13029-139E5 |
10.57 | 3.34 |
| Adipocyte differentiation, day12, donor1 | 13021-139D6 |
12.06 | 2.08 |
| Adipocyte differentiation, day12, donor2 | 13024-139D9 |
14.32 | 2.01 |
| Adipocyte differentiation, day12, donor3 | 13027-139E3 |
11.78 | 1.31 |
| Adipocyte differentiation, day12, donor4 | 13030-139E6 |
10.05 | 2.13 |
| Alveolar Epithelial Cells, donor1 | 11510-119G7 |
15.25 | 2.65 |
| Alveolar Epithelial Cells, donor2 | 11590-120G6 |
3.94 | 0.72 |
| Alveolar Epithelial Cells, donor3 | 11671-122G6 |
2.40 | 0.00 |
| Amniotic Epithelial Cells, donor1 | 11533-120A3 |
10.97 | 3.60 |
| Amniotic Epithelial Cells, donor2 | 11613-122A2 |
8.37 | 1.67 |
| Amniotic Epithelial Cells, donor3 | 11694-123A2 |
6.57 | 1.44 |
| Anulus Pulposus Cell, donor1 | 11248-116E6 |
25.75 | 8.01 |
| Anulus Pulposus Cell, donor2 | 11463-119B5 |
20.82 | 4.90 |
| Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1) | 12642-134G5 |
21.12 | 4.04 |
| Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2) | 12740-135I4 |
23.44 | 3.47 |
| Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3) | 12838-137B3 |
19.26 | 4.28 |
| Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4) | 12643-134G6 |
23.91 | 3.89 |
| Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5) | 12741-135I5 |
12.65 | 3.79 |
| Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6) | 12839-137B4 |
11.88 | 2.64 |
| Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7) | 12644-134G7 |
22.42 | 6.82 |
| Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8) | 12742-135I6 |
25.24 | 4.85 |
| Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9) | 12840-137B5 |
15.44 | 4.75 |
| Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10) | 12645-134G8 |
27.49 | 3.39 |
| Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11) | 12743-135I7 |
26.85 | 7.26 |
| Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12) | 12841-137B6 |
26.33 | 6.27 |
| Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13) | 12646-134G9 |
25.37 | 8.90 |
| Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14) | 12744-135I8 |
27.30 | 4.09 |
| Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15) | 12842-137B7 |
22.92 | 4.67 |
| Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16) | 12647-134H1 |
32.15 | 4.29 |
| Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17) | 12745-135I9 |
18.33 | 4.35 |
| Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18) | 12843-137B8 |
18.44 | 4.28 |
| Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19) | 12648-134H2 |
33.17 | 3.90 |
| Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20) | 12746-136A1 |
17.25 | 4.64 |
| Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21) | 12844-137B9 |
8.41 | 7.20 |
| Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22) | 12649-134H3 |
31.86 | 7.08 |
| Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23) | 12747-136A2 |
20.07 | 4.80 |
| Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24) | 12845-137C1 |
25.17 | 4.19 |
| Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25) | 12650-134H4 |
24.76 | 2.43 |
| Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26) | 12748-136A3 |
20.87 | 6.45 |
| Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27) | 12846-137C2 |
16.96 | 8.48 |
| Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28) | 12651-134H5 |
22.80 | 5.13 |
| Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29) | 12749-136A4 |
19.03 | 6.20 |
| Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30) | 12847-137C3 |
17.55 | 5.42 |
| Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31) | 12652-134H6 |
20.65 | 7.98 |
| Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32) | 12750-136A5 |
20.90 | 5.14 |
| Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33) | 12848-137C4 |
17.12 | 4.28 |
| Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34) | 12653-134H7 |
17.55 | 7.60 |
| Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35) | 12751-136A6 |
22.58 | 6.02 |
| Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36) | 12849-137C5 |
16.63 | 5.94 |
| Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37) | 12654-134H8 |
24.92 | 5.59 |
| Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38) | 12752-136A7 |
13.50 | 3.82 |
| Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39) | 12850-137C6 |
15.25 | 3.18 |
| Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40) | 12655-134H9 |
24.60 | 2.59 |
| Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41) | 12753-136A8 |
15.24 | 4.87 |
| Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42) | 12851-137C7 |
15.37 | 4.06 |
| Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43) | 12656-134I1 |
30.23 | 3.78 |
| Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44) | 12754-136A9 |
15.60 | 3.73 |
| Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45) | 12852-137C8 |
11.58 | 2.32 |
| Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46) | 12657-134I2 |
31.69 | 6.34 |
| Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47) | 12755-136B1 |
21.66 | 3.22 |
| Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48) | 12853-137C9 |
20.46 | 4.81 |
| Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49) | 12658-134I3 |
27.70 | 5.10 |
| Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50) | 12756-136B2 |
16.09 | 3.22 |
| Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51) | 12854-137D1 |
15.30 | 2.55 |
| Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52) | 12659-134I4 |
21.36 | 6.10 |
| Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53) | 12757-136B3 |
21.47 | 4.95 |
| Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54) | 12855-137D2 |
16.83 | 4.90 |
| Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55) | 12660-134I5 |
35.85 | 3.35 |
| Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56) | 12758-136B4 |
22.17 | 5.77 |
| Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57) | 12856-137D3 |
21.36 | 4.58 |
| Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58) | 12661-134I6 |
27.14 | 6.09 |
| Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59) | 12759-136B5 |
18.80 | 5.03 |
| Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60) | 12857-137D4 |
20.72 | 5.09 |
| Astrocyte - cerebellum, donor1 | 11500-119F6 |
16.83 | 1.72 |
| Astrocyte - cerebellum, donor2 | 11580-120F5 |
11.47 | 2.23 |
| Astrocyte - cerebellum, donor3 | 11661-122F5 |
6.08 | 1.26 |
| Astrocyte - cerebral cortex, donor1 | 11235-116D2 |
31.02 | 6.27 |
| Astrocyte - cerebral cortex, donor2 | 11316-117D2 |
30.74 | 7.28 |
| Astrocyte - cerebral cortex, donor3 | 11392-118C6 |
34.01 | 5.67 |
| B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1 | 10821-111C2 |
19.61 | 4.47 |
| B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2 | 10822-111C3 |
17.66 | 5.51 |
| B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3 | 10823-111C4 |
23.10 | 4.67 |
| Basophils, donor1 | 12241-129G9 |
2.09 | 0.26 |
| Basophils, donor2 | 12242-129H1 |
0.72 | 0.72 |
| Basophils, donor3 | 12243-129H2 |
1.47 | 0.59 |
| Bronchial Epithelial Cell, donor1 | 11511-119G8 |
5.17 | 0.22 |
| Bronchial Epithelial Cell, donor2 | 11591-120G7 |
0.91 | 0.46 |
| Bronchial Epithelial Cell, donor3 | 11672-122G7 |
28.69 | 0.00 |
| Bronchial Epithelial Cell, donor4 | 11453-119A4 |
9.41 | 1.88 |
| Bronchial Epithelial Cell, donor5 | 11457-119A8 |
8.53 | 1.04 |
| Bronchial Epithelial Cell, donor6 | 11461-119B3 |
8.06 | 1.84 |
| Bronchial Epithelial Cell, donor7 | 11769-123I5 |
13.50 | 3.96 |
| Burkitt's lymphoma cell line:DAUDI | 10422-106C8 |
0.00 | 0.00 |
| Burkitt's lymphoma cell line:RAJI | 10476-106I8 |
14.91 | 2.10 |
| CD133+ stem cells - adult bone marrow derived, pool1 | 12224-129F1 |
18.87 | 5.44 |
| CD133+ stem cells - cord blood derived, pool1 | 12223-129E9 |
0.00 | 0.00 |
| CD14+ Monocytes, donor1 | 11224-116B9 |
2.82 | 0.56 |
| CD14+ Monocytes, donor2 | 11305-117B9 |
2.23 | 0.19 |
| CD14+ Monocytes, donor3 | 11381-118B4 |
1.76 | 1.10 |
| CD14+ monocyte derived endothelial progenitor cells, donor1 | 11229-116C5 |
13.59 | 2.26 |
| CD14+ monocyte derived endothelial progenitor cells, donor2 | 11310-117C5 |
17.82 | 5.31 |
| CD14+ monocyte derived endothelial progenitor cells, donor3 | 11386-118B9 |
12.16 | 4.93 |
| CD14+ monocytes - mock treated, donor1 | 11863-125A9 |
4.77 | 0.58 |
| CD14+ monocytes - mock treated, donor2 | 11873-125C1 |
5.43 | 1.51 |
| CD14+ monocytes - mock treated, donor3 | 11883-125D2 |
6.16 | 1.90 |
| CD14+ monocytes - treated with B-glucan, donor1 | 11869-125B6 |
2.01 | 0.33 |
| CD14+ monocytes - treated with B-glucan, donor2 | 11879-125C7 |
5.80 | 0.83 |
| CD14+ monocytes - treated with B-glucan, donor3 | 11889-125D8 |
2.98 | 1.24 |
| CD14+ monocytes - treated with BCG, donor1 | 11860-125A6 |
1.57 | 0.20 |
| CD14+ monocytes - treated with BCG, donor2 | 11870-125B7 |
3.03 | 0.71 |
| CD14+ monocytes - treated with BCG, donor3 | 11880-125C8 |
1.96 | 0.65 |
| CD14+ monocytes - treated with Candida, donor1 | 11868-125B5 |
1.87 | 0.94 |
| CD14+ monocytes - treated with Candida, donor2 | 11878-125C6 |
1.06 | 1.06 |
| CD14+ monocytes - treated with Candida, donor3 | 11888-125D7 |
2.22 | 0.00 |
| CD14+ monocytes - treated with Cryptococcus, donor1 | 11867-125B4 |
1.78 | 0.30 |
| CD14+ monocytes - treated with Cryptococcus, donor2 | 11877-125C5 |
4.59 | 0.80 |
| CD14+ monocytes - treated with Cryptococcus, donor3 | 11887-125D6 |
3.96 | 1.04 |
| CD14+ monocytes - treated with Group A streptococci, donor1 | 11864-125B1 |
1.60 | 0.92 |
| CD14+ monocytes - treated with Group A streptococci, donor2 | 11874-125C2 |
3.17 | 0.68 |
| CD14+ monocytes - treated with Group A streptococci, donor3 | 11884-125D3 |
2.62 | 0.87 |
| CD14+ monocytes - treated with IFN + N-hexane, donor1 | 11861-125A7 |
1.34 | 0.81 |
| CD14+ monocytes - treated with IFN + N-hexane, donor2 | 11871-125B8 |
3.84 | 0.35 |
| CD14+ monocytes - treated with IFN + N-hexane, donor3 | 11881-125C9 |
3.79 | 0.84 |
| CD14+ monocytes - treated with Salmonella, donor1 | 11866-125B3 |
4.04 | 0.37 |
| CD14+ monocytes - treated with Salmonella, donor2 | 11876-125C4 |
3.87 | 1.41 |
| CD14+ monocytes - treated with Salmonella, donor3 | 11886-125D5 |
7.90 | 1.32 |
| CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1 | 11862-125A8 |
0.87 | 0.17 |
| CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2 | 11872-125B9 |
2.60 | 1.12 |
| CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3 | 11882-125D1 |
2.59 | 1.29 |
| CD14+ monocytes - treated with lipopolysaccharide, donor1 | 11865-125B2 |
4.91 | 0.00 |
| CD14+ monocytes - treated with lipopolysaccharide, donor2 | 11875-125C3 |
2.55 | 0.70 |
| CD14+ monocytes - treated with lipopolysaccharide, donor3 | 11885-125D4 |
3.94 | 1.62 |
| CD14+CD16+ Monocytes, donor1 | 11789-124B7 |
6.76 | 1.96 |
| CD14+CD16+ Monocytes, donor2 | 11801-124D1 |
8.08 | 1.39 |
| CD14+CD16+ Monocytes, donor3 | 11912-125G4 |
6.28 | 1.73 |
| CD14+CD16- Monocytes, donor1 | 11788-124B6 |
9.03 | 2.80 |
| CD14+CD16- Monocytes, donor2 | 11799-124C8 |
6.64 | 2.10 |
| CD14+CD16- Monocytes, donor3 | 11910-125G2 |
6.24 | 1.34 |
| CD14-CD16+ Monocytes, donor1 | 11790-124B8 |
9.44 | 2.30 |
| CD14-CD16+ Monocytes, donor2 | 11800-124C9 |
11.64 | 2.42 |
| CD14-CD16+ Monocytes, donor3 | 11911-125G3 |
7.37 | 0.63 |
| CD19+ B Cells (pluriselect), donor090309, donation1 | 12189-129B2 |
10.16 | 2.03 |
| CD19+ B Cells (pluriselect), donor090309, donation2 | 12194-129B7 |
12.20 | 4.07 |
| CD19+ B Cells (pluriselect), donor090309, donation3 | 12199-129C3 |
10.36 | 6.21 |
| CD19+ B Cells (pluriselect), donor090325, donation1 | 12151-128F9 |
17.06 | 3.73 |
| CD19+ B Cells (pluriselect), donor090325, donation2 | 12174-128I5 |
9.11 | 2.68 |
| CD19+ B Cells (pluriselect), donor090612, donation1 | 12204-129C8 |
9.13 | 6.32 |
| CD19+ B Cells (pluriselect), donor090612, donation2 | 12209-129D4 |
16.47 | 3.14 |
| CD19+ B Cells (pluriselect), donor090612, donation3 | 12214-129D9 |
10.55 | 0.00 |
| CD19+ B Cells, donor1 | 11544-120B5 |
1.64 | 0.00 |
| CD19+ B Cells, donor2 | 11624-122B4 |
1.45 | 0.00 |
| CD19+ B Cells, donor3 | 11705-123B4 |
1.51 | 0.00 |
| CD34 cells differentiated to erythrocyte lineage, biol_ rep1 | 11931-125I5 |
572.14 | 43.64 |
| CD34 cells differentiated to erythrocyte lineage, biol_ rep2 | 11932-125I6 |
504.56 | 40.75 |
| CD34+ Progenitors, donor1 | 11545-120B6 |
20.08 | 2.01 |
| CD34+ Progenitors, donor2 | 11625-122B5 |
12.36 | 1.12 |
| CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1 | 12225-129F2 |
82.67 | 6.01 |
| CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2 | 12225-129F2 |
67.42 | 5.64 |
| CD4+ T Cells, donor1 | 11225-116C1 |
1.43 | 0.36 |
| CD4+ T Cells, donor2 | 11306-117C1 |
3.06 | 0.61 |
| CD4+ T Cells, donor3 | 11382-118B5 |
2.13 | 0.91 |
| CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1 | 11793-124C2 |
22.21 | 6.64 |
| CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2 | 11915-125G7 |
20.66 | 6.96 |
| CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3 | 11919-125H2 |
25.58 | 11.21 |
| CD4+CD25+CD45RA+ naive regulatory T cells, donor1 | 11780-124A7 |
9.96 | 2.37 |
| CD4+CD25+CD45RA+ naive regulatory T cells, donor2 | 11796-124C5 |
11.94 | 4.21 |
| CD4+CD25+CD45RA+ naive regulatory T cells, donor3 | 11907-125F8 |
6.59 | 3.30 |
| CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1 | 11794-124C3 |
21.39 | 8.24 |
| CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2 | 11916-125G8 |
19.32 | 9.32 |
| CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3 | 11920-125H3 |
15.80 | 8.06 |
| CD4+CD25+CD45RA- memory regulatory T cells, donor1 | 11782-124A9 |
8.97 | 2.69 |
| CD4+CD25+CD45RA- memory regulatory T cells, donor2 | 11797-124C6 |
15.02 | 1.05 |
| CD4+CD25+CD45RA- memory regulatory T cells, donor3 | 11908-125F9 |
8.80 | 3.52 |
| CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1 | 11791-124B9 |
12.65 | 10.12 |
| CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2 | 11913-125G5 |
15.37 | 5.82 |
| CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3 | 11917-125G9 |
16.71 | 5.68 |
| CD4+CD25-CD45RA+ naive conventional T cells, donor1 | 11784-124B2 |
13.32 | 6.25 |
| CD4+CD25-CD45RA+ naive conventional T cells, donor2 | 11795-124C4 |
12.33 | 1.07 |
| CD4+CD25-CD45RA+ naive conventional T cells, donor3 | 11906-125F7 |
5.38 | 8.97 |
| CD4+CD25-CD45RA- memory conventional T cells expanded, donor1 | 11792-124C1 |
16.32 | 9.64 |
| CD4+CD25-CD45RA- memory conventional T cells expanded, donor2 | 11914-125G6 |
13.21 | 4.33 |
| CD4+CD25-CD45RA- memory conventional T cells expanded, donor3 | 11918-125H1 |
16.39 | 6.94 |
| CD4+CD25-CD45RA- memory conventional T cells, donor1 | 11786-124B4 |
6.07 | 3.03 |
| CD4+CD25-CD45RA- memory conventional T cells, donor2 | 11798-124C7 |
6.50 | 2.60 |
| CD4+CD25-CD45RA- memory conventional T cells, donor3 | 11909-125G1 |
6.10 | 3.49 |
| CD8+ T Cells (pluriselect), donor090309, donation1 | 12186-129A8 |
11.88 | 3.96 |
| CD8+ T Cells (pluriselect), donor090309, donation2 | 12191-129B4 |
11.08 | 2.77 |
| CD8+ T Cells (pluriselect), donor090309, donation3 | 12196-129B9 |
12.56 | 0.00 |
| CD8+ T Cells (pluriselect), donor090325, donation1 | 12148-128F6 |
20.49 | 5.26 |
| CD8+ T Cells (pluriselect), donor090325, donation2 | 12171-128I2 |
19.14 | 4.66 |
| CD8+ T Cells (pluriselect), donor090612, donation1 | 12201-129C5 |
24.64 | 12.32 |
| CD8+ T Cells (pluriselect), donor090612, donation2 | 12206-129D1 |
15.76 | 5.01 |
| CD8+ T Cells (pluriselect), donor090612, donation3 | 12211-129D6 |
12.46 | 9.69 |
| CD8+ T Cells, donor1 | 11226-116C2 |
2.62 | 0.98 |
| CD8+ T Cells, donor2 | 11307-117C2 |
1.50 | 0.00 |
| CD8+ T Cells, donor3 | 11383-118B6 |
5.05 | 0.50 |
| COBL-a rinderpest infection, 00hr, biol_rep1 | 13553-145I7 |
22.94 | 6.42 |
| COBL-a rinderpest infection, 00hr, biol_rep2 | 13554-145I8 |
22.29 | 5.99 |
| COBL-a rinderpest infection, 00hr, biol_rep3 | 13555-145I9 |
23.26 | 4.92 |
| COBL-a rinderpest infection, 06hr, biol_rep1 | 13556-146A1 |
17.71 | 3.90 |
| COBL-a rinderpest infection, 06hr, biol_rep2 | 13557-146A2 |
30.24 | 7.68 |
| COBL-a rinderpest infection, 06hr, biol_rep3 | 13558-146A3 |
22.74 | 5.23 |
| COBL-a rinderpest infection, 12hr, biol_rep1 | 13559-146A4 |
27.60 | 5.65 |
| COBL-a rinderpest infection, 12hr, biol_rep2 | 13560-146A5 |
27.37 | 6.05 |
| COBL-a rinderpest infection, 12hr, biol_rep3 | 13561-146A6 |
26.27 | 5.63 |
| COBL-a rinderpest infection, 24hr, biol_rep1 | 13562-146A7 |
28.07 | 4.23 |
| COBL-a rinderpest infection, 24hr, biol_rep2 | 13563-146A8 |
26.44 | 4.36 |
| COBL-a rinderpest infection, 24hr, biol_rep3 | 13564-146A9 |
29.84 | 4.26 |
| COBL-a rinderpest infection, 48hr, biol_rep1 | 13565-146B1 |
36.77 | 1.75 |
| COBL-a rinderpest infection, 48hr, biol_rep2 | 13566-146B2 |
37.80 | 5.01 |
| COBL-a rinderpest infection, 48hr, biol_rep3 | 13567-146B3 |
29.83 | 5.97 |
| COBL-a rinderpest(-C) infection, 06hr, biol_rep1 | 13568-146B4 |
25.21 | 6.12 |
| COBL-a rinderpest(-C) infection, 06hr, biol_rep2 | 13569-146B5 |
25.03 | 7.48 |
| COBL-a rinderpest(-C) infection, 06hr, biol_rep3 | 13570-146B6 |
22.39 | 4.71 |
| COBL-a rinderpest(-C) infection, 12hr, biol_rep1 | 13571-146B7 |
29.79 | 4.75 |
| COBL-a rinderpest(-C) infection, 12hr, biol_rep2 | 13572-146B8 |
32.60 | 6.46 |
| COBL-a rinderpest(-C) infection, 12hr, biol_rep3 | 13573-146B9 |
31.10 | 3.53 |
| COBL-a rinderpest(-C) infection, 24hr, biol_rep1 | 13574-146C1 |
26.01 | 4.97 |
| COBL-a rinderpest(-C) infection, 24hr, biol_rep2 | 13575-146C2 |
31.53 | 4.34 |
| COBL-a rinderpest(-C) infection, 24hr, biol_rep3 | 13576-146C3 |
28.74 | 6.05 |
| COBL-a rinderpest(-C) infection, 48hr, biol_rep1 | 13577-146C4 |
34.53 | 7.23 |
| COBL-a rinderpest(-C) infection, 48hr, biol_rep2 | 13578-146C5 |
41.97 | 6.29 |
| COBL-a rinderpest(-C) infection, 48hr, biol_rep3 | 13579-146C6 |
51.09 | 4.01 |
| Cardiac Myocyte, donor1 | 11525-119I4 |
38.38 | 9.14 |
| Cardiac Myocyte, donor2 | 11605-120I3 |
31.13 | 7.91 |
| Cardiac Myocyte, donor3 | 11686-122I3 |
24.83 | 4.84 |
| Chondrocyte - de diff, donor1 | 11261-116G1 |
25.31 | 3.12 |
| Chondrocyte - de diff, donor2 | 11338-117F6 |
18.48 | 3.91 |
| Chondrocyte - de diff, donor3 | 11410-118E6 |
25.94 | 5.35 |
| Chondrocyte - re diff, donor2 | 11339-117F7 |
17.91 | 3.58 |
| Chondrocyte - re diff, donor3 | 11411-118E7 |
21.43 | 8.09 |
| Ciliary Epithelial Cells, donor1 | 11242-116D9 |
30.53 | 8.38 |
| Ciliary Epithelial Cells, donor2 | 11323-117D9 |
24.58 | 5.56 |
| Ciliary Epithelial Cells, donor3 | 11399-118D4 |
26.02 | 6.55 |
| Clontech Human Universal Reference Total RNA, pool1 | 10000-101A1 |
17.61 | 3.48 |
| Corneal Epithelial Cells, donor1 | 11526-119I5 |
3.95 | 0.44 |
| Corneal Epithelial Cells, donor2 | 11606-120I4 |
4.55 | 3.41 |
| Corneal Epithelial Cells, donor3 | 11687-122I4 |
5.62 | 0.51 |
| Dendritic Cells - monocyte immature derived, donor1, rep2 | 11227-116C3 |
10.57 | 2.81 |
| Dendritic Cells - monocyte immature derived, donor1, tech_rep1 | 11227-116C3 |
10.72 | 3.15 |
| Dendritic Cells - monocyte immature derived, donor2 | 11308-117C3 |
0.00 | 10.35 |
| Dendritic Cells - monocyte immature derived, donor3 | 11384-118B7 |
10.69 | 3.78 |
| Dendritic Cells - plasmacytoid, donor1 | 11228-116C4 |
2.05 | 0.34 |
| Dendritic Cells - plasmacytoid, donor2 | 11309-117C4 |
1.96 | 0.65 |
| Dendritic Cells - plasmacytoid, donor3 | 11385-118B8 |
0.97 | 0.97 |
| Endothelial Cells - Aortic, donor0 | 11207-116A1 |
9.67 | 1.67 |
| Endothelial Cells - Aortic, donor1 | 11263-116G3 |
12.91 | 2.93 |
| Endothelial Cells - Aortic, donor2 | 11340-117F8 |
9.62 | 0.85 |
| Endothelial Cells - Aortic, donor3 | 11412-118E8 |
17.30 | 1.97 |
| Endothelial Cells - Artery, donor1 | 11264-116G4 |
12.22 | 0.58 |
| Endothelial Cells - Artery, donor2 | 11341-117F9 |
13.18 | 1.18 |
| Endothelial Cells - Artery, donor3 | 11413-118E9 |
12.10 | 1.58 |
| Endothelial Cells - Lymphatic, donor1 | 11236-116D3 |
16.85 | 2.44 |
| Endothelial Cells - Lymphatic, donor2 | 11317-117D3 |
13.69 | 2.74 |
| Endothelial Cells - Lymphatic, donor3 | 11393-118C7 |
17.48 | 2.82 |
| Endothelial Cells - Microvascular, donor1 | 11265-116G5 |
11.29 | 1.78 |
| Endothelial Cells - Microvascular, donor2 | 11342-117G1 |
7.29 | 3.12 |
| Endothelial Cells - Microvascular, donor3 | 11414-118F1 |
6.95 | 1.99 |
| Endothelial Cells - Thoracic, donor1 | 11266-116G6 |
28.81 | 2.00 |
| Endothelial Cells - Thoracic, donor2 | 11343-117G2 |
17.82 | 2.62 |
| Endothelial Cells - Umbilical vein, donor1 | 11243-116E1 |
27.21 | 3.98 |
| Endothelial Cells - Umbilical vein, donor2 | 11324-117E1 |
11.73 | 3.04 |
| Endothelial Cells - Umbilical vein, donor3 | 11400-118D5 |
13.56 | 1.95 |
| Endothelial Cells - Vein, donor1 | 11267-116G7 |
10.24 | 2.28 |
| Endothelial Cells - Vein, donor2 | 11344-117G3 |
18.16 | 1.40 |
| Endothelial Cells - Vein, donor3 | 11416-118F3 |
16.01 | 3.61 |
| Eosinophils, donor1 | 12244-129H3 |
0.00 | 0.00 |
| Eosinophils, donor2 | 12245-129H4 |
1.65 | 0.00 |
| Eosinophils, donor3 | 12246-129H5 |
0.00 | 0.00 |
| Esophageal Epithelial Cells, donor1 | 11507-119G4 |
5.38 | 0.24 |
| Esophageal Epithelial Cells, donor2 | 11587-120G3 |
0.00 | 0.00 |
| Esophageal Epithelial Cells, donor3 | 11668-122G3 |
32.54 | 0.00 |
| Ewing's sarcoma cell line:Hs 863.T | 10705-109H3 |
19.70 | 4.93 |
| Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction) | 14331-155F2 |
14.34 | 4.05 |
| Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction) | 14310-155C8 |
2.06 | 0.87 |
| Fibroblast - Aortic Adventitial, donor1 | 11245-116E3 |
24.13 | 4.73 |
| Fibroblast - Aortic Adventitial, donor2 (nuclear fraction) | 14332-155F3 |
38.89 | 6.41 |
| Fibroblast - Aortic Adventitial, donor2 | 11326-117E3 |
16.98 | 4.22 |
| Fibroblast - Aortic Adventitial, donor3 (nuclear fraction) | 14311-155C9 |
77.73 | 16.07 |
| Fibroblast - Aortic Adventitial, donor3 | 11401-118D6 |
19.93 | 3.65 |
| Fibroblast - Cardiac, donor1 | 11268-116G8 |
18.60 | 5.44 |
| Fibroblast - Cardiac, donor2 | 11345-117G4 |
8.34 | 2.27 |
| Fibroblast - Cardiac, donor3 | 11417-118F4 |
12.62 | 3.31 |
| Fibroblast - Cardiac, donor4 | 11452-119A3 |
31.22 | 6.37 |
| Fibroblast - Cardiac, donor5 | 11456-119A7 |
24.87 | 3.17 |
| Fibroblast - Cardiac, donor6 | 11460-119B2 |
30.62 | 4.85 |
| Fibroblast - Choroid Plexus, donor1 | 11492-119E7 |
21.71 | 4.02 |
| Fibroblast - Choroid Plexus, donor2 | 11572-120E6 |
27.18 | 6.04 |
| Fibroblast - Choroid Plexus, donor3 | 11653-122E6 |
20.51 | 8.79 |
| Fibroblast - Conjunctival, donor1 | 11531-120A1 |
7.84 | 0.92 |
| Fibroblast - Conjunctival, donor3 | 11692-122I9 |
28.66 | 7.80 |
| Fibroblast - Dermal, donor1 | 11269-116G9 |
22.30 | 7.75 |
| Fibroblast - Dermal, donor2 | 11346-117G5 |
6.60 | 3.30 |
| Fibroblast - Dermal, donor3 | 11418-118F5 |
18.74 | 4.96 |
| Fibroblast - Dermal, donor4 | 11450-119A1 |
17.86 | 1.47 |
| Fibroblast - Dermal, donor5 | 11454-119A5 |
23.38 | 1.74 |
| Fibroblast - Dermal, donor6 | 11458-119A9 |
20.95 | 4.39 |
| Fibroblast - Gingival, donor1 | 11237-116D4 |
24.78 | 7.08 |
| Fibroblast - Gingival, donor10 (periodontitis) | 11928-125I2 |
23.32 | 5.24 |
| Fibroblast - Gingival, donor2 | 11318-117D4 |
27.02 | 4.88 |
| Fibroblast - Gingival, donor3 | 11394-118C8 |
22.72 | 4.45 |
| Fibroblast - Gingival, donor4 (GFH2) | 11222-116B7 |
9.35 | 1.04 |
| Fibroblast - Gingival, donor5 (GFH3) | 11303-117B7 |
12.51 | 3.70 |
| Fibroblast - Gingival, donor6 (aggressive periodontitis) | 11921-125H4 |
24.16 | 5.61 |
| Fibroblast - Gingival, donor6 (control) | 11922-125H5 |
21.37 | 4.87 |
| Fibroblast - Gingival, donor7 (aggressive periodontitis) | 11923-125H6 |
27.88 | 5.65 |
| Fibroblast - Gingival, donor7 (control) | 11924-125H7 |
20.04 | 5.26 |
| Fibroblast - Gingival, donor8 (chronic periodontitis) | 11925-125H8 |
19.23 | 3.95 |
| Fibroblast - Gingival, donor8 (control) | 11926-125H9 |
19.64 | 4.17 |
| Fibroblast - Gingival, donor9 (control) | 11927-125I1 |
19.37 | 5.43 |
| Fibroblast - Lung, donor1 | 11270-116H1 |
8.16 | 1.36 |
| Fibroblast - Lung, donor2 | 11347-117G6 |
20.89 | 8.95 |
| Fibroblast - Lung, donor3 | 11419-118F6 |
23.00 | 3.59 |
| Fibroblast - Lymphatic, donor1 | 11506-119G3 |
17.49 | 1.67 |
| Fibroblast - Lymphatic, donor2 | 11586-120G2 |
16.78 | 0.00 |
| Fibroblast - Lymphatic, donor3 | 11667-122G2 |
5.32 | 1.40 |
| Fibroblast - Mammary, donor1 | 11540-120B1 |
15.43 | 2.03 |
| Fibroblast - Mammary, donor2 | 11620-122A9 |
0.00 | 3.99 |
| Fibroblast - Mammary, donor3 | 11701-123A9 |
11.91 | 5.96 |
| Fibroblast - Periodontal Ligament, donor1 | 11238-116D5 |
27.35 | 6.01 |
| Fibroblast - Periodontal Ligament, donor2 | 11319-117D5 |
27.45 | 5.31 |
| Fibroblast - Periodontal Ligament, donor3 | 11395-118C9 |
29.99 | 5.51 |
| Fibroblast - Periodontal Ligament, donor4 (PL29) | 11223-116B8 |
14.50 | 3.82 |
| Fibroblast - Periodontal Ligament, donor5 (PL30) | 11304-117B8 |
14.04 | 0.81 |
| Fibroblast - Periodontal Ligament, donor6 (PLH3) | 11380-118B3 |
18.79 | 5.10 |
| Fibroblast - Pulmonary Artery, donor1 | 11250-116E8 |
29.73 | 5.64 |
| Fibroblast - Villous Mesenchymal, donor1 | 11535-120A5 |
25.40 | 2.84 |
| Fibroblast - Villous Mesenchymal, donor2 | 11615-122A4 |
6.68 | 0.67 |
| Fibroblast - Villous Mesenchymal, donor3 | 11696-123A4 |
26.09 | 3.95 |
| Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction) | 14329-155E9 |
61.12 | 11.51 |
| Fibroblast - skin dystrophia myotonica, donor1 | 11556-120C8 |
16.52 | 3.91 |
| Fibroblast - skin dystrophia myotonica, donor2 | 11557-120C9 |
22.07 | 5.32 |
| Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction) | 14308-155C6 |
61.68 | 14.14 |
| Fibroblast - skin dystrophia myotonica, donor3 | 11560-120D3 |
22.24 | 3.67 |
| Fibroblast - skin normal, donor1 (nuclear fraction) | 14323-155E3 |
40.49 | 7.09 |
| Fibroblast - skin normal, donor1 | 11553-120C5 |
21.17 | 4.92 |
| Fibroblast - skin normal, donor2 (nuclear fraction) | 14302-155B9 |
59.55 | 12.23 |
| Fibroblast - skin normal, donor2 | 11561-120D4 |
20.80 | 5.02 |
| Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction) | 14326-155E6 |
41.71 | 9.37 |
| Fibroblast - skin spinal muscular atrophy, donor1 | 11555-120C7 |
25.27 | 4.56 |
| Fibroblast - skin spinal muscular atrophy, donor2 | 11558-120D1 |
29.23 | 5.13 |
| Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction) | 14305-155C3 |
60.10 | 9.85 |
| Fibroblast - skin spinal muscular atrophy, donor3 | 11559-120D2 |
21.20 | 3.52 |
| Fibroblast - skin walker warburg, donor1 | 11554-120C6 |
23.28 | 4.22 |
| Fibroblast - skin, normal donor1 (cytoplasmic fraction) | 14322-155E2 |
9.25 | 4.55 |
| Fibroblast - skin, normal donor2 (cytoplasmic fraction) | 14301-155B8 |
22.16 | 0.00 |
| Fingernail (including nail plate, eponychium and hyponychium), donor2 | 10301-104H4 |
14.82 | 8.72 |
| Gingival epithelial cells, donor1 (GEA11) | 11221-116B6 |
16.12 | 4.85 |
| Gingival epithelial cells, donor2 (GEA14) | 11302-117B6 |
20.82 | 3.64 |
| Gingival epithelial cells, donor3 (GEA15) | 11379-118B2 |
16.86 | 3.58 |
| H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1 | 13523-145F4 |
24.50 | 3.06 |
| H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2 | 13524-145F5 |
28.71 | 3.19 |
| H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3 | 13525-145F6 |
25.67 | 7.13 |
| H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1 | 13526-145F7 |
47.15 | 11.86 |
| H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2 | 13527-145F8 |
31.05 | 10.73 |
| H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3 | 13528-145F9 |
32.89 | 7.33 |
| H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1 | 13529-145G1 |
41.76 | 11.37 |
| H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2 | 13530-145G2 |
30.98 | 9.78 |
| H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3 | 13531-145G3 |
34.94 | 11.94 |
| H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0) | 12627-134E8 |
25.16 | 5.23 |
| H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0) | 12725-135G7 |
26.97 | 5.54 |
| H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0) | 12823-136I6 |
27.67 | 5.91 |
| H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1) | 12628-134E9 |
27.75 | 6.57 |
| H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1) | 12726-135G8 |
27.69 | 5.81 |
| H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1) | 12824-136I7 |
27.85 | 6.71 |
| H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3) | 12629-134F1 |
27.84 | 5.25 |
| H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3) | 12727-135G9 |
22.30 | 5.73 |
| H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3) | 12825-136I8 |
17.49 | 6.56 |
| H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6) | 12630-134F2 |
27.18 | 5.91 |
| H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6) | 12728-135H1 |
30.84 | 5.88 |
| H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6) | 12826-136I9 |
29.27 | 6.26 |
| H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9) | 12631-134F3 |
25.41 | 5.44 |
| H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9) | 12729-135H2 |
25.79 | 7.46 |
| H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9) | 12827-137A1 |
39.10 | 6.83 |
| H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12) | 12632-134F4 |
26.64 | 6.35 |
| H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12) | 12632-134F4 |
27.49 | 5.98 |
| H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12) | 12730-135H3 |
26.11 | 6.42 |
| H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12) | 12828-137A2 |
34.44 | 5.74 |
| H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12) | 12828-137A2 |
31.04 | 4.49 |
| H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15) | 12633-134F5 |
22.07 | 5.36 |
| H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15) | 12731-135H4 |
29.86 | 5.88 |
| H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15) | 12829-137A3 |
22.35 | 6.00 |
| H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18) | 12634-134F6 |
22.04 | 7.05 |
| H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18) | 12732-135H5 |
29.03 | 6.52 |
| H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18) | 12830-137A4 |
26.75 | 6.81 |
| H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21) | 12635-134F7 |
22.45 | 7.38 |
| H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21) | 12733-135H6 |
20.09 | 4.93 |
| H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21) | 12831-137A5 |
19.30 | 5.54 |
| H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24) | 12636-134F8 |
17.33 | 5.17 |
| H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24) | 12734-135H7 |
22.27 | 5.54 |
| H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24) | 12832-137A6 |
18.00 | 4.83 |
| H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27) | 12637-134F9 |
24.13 | 5.33 |
| H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27) | 12735-135H8 |
22.78 | 5.00 |
| H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27) | 12833-137A7 |
20.06 | 5.35 |
| H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30) | 12638-134G1 |
20.20 | 5.81 |
| H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30) | 12736-135H9 |
23.83 | 4.53 |
| H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30) | 12834-137A8 |
22.77 | 3.25 |
| H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34) | 12639-134G2 |
23.97 | 5.35 |
| H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34) | 12737-135I1 |
21.49 | 5.26 |
| H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34) | 12835-137A9 |
25.79 | 7.93 |
| H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41) | 12640-134G3 |
22.16 | 4.75 |
| H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41) | 12738-135I2 |
25.42 | 7.87 |
| H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41) | 12836-137B1 |
25.16 | 4.57 |
| H9 Embryonic Stem cells, biol_rep1 (H9ES-1) | 12626-134E7 |
35.43 | 5.37 |
| H9 Embryonic Stem cells, biol_rep2 (H9ES-2) | 12724-135G6 |
26.96 | 5.24 |
| H9 Embryonic Stem cells, biol_rep3 (H9ES-3) | 12822-136I5 |
37.44 | 7.16 |
| HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1) | 13364-143F7 |
39.43 | 5.63 |
| HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2) | 13365-143F8 |
31.65 | 6.78 |
| HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3) | 13366-143F9 |
44.74 | 5.53 |
| HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1 | 13328-143B7 |
27.22 | 7.42 |
| HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2 | 13340-143D1 |
42.55 | 7.35 |
| HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3 | 13352-143E4 |
44.93 | 3.21 |
| HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1 | 13329-143B8 |
38.25 | 5.22 |
| HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2 | 13341-143D2 |
36.13 | 8.46 |
| HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3 | 13353-143E5 |
37.47 | 5.35 |
| HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1 | 13330-143B9 |
33.32 | 13.33 |
| HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2 | 13342-143D3 |
36.07 | 6.71 |
| HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3 | 13354-143E6 |
38.57 | 6.54 |
| HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1 | 13331-143C1 |
39.43 | 9.23 |
| HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2 | 13343-143D4 |
41.35 | 10.50 |
| HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3 | 13355-143E7 |
29.89 | 9.51 |
| HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1 | 13332-143C2 |
50.12 | 8.35 |
| HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2 | 13344-143D5 |
40.09 | 7.45 |
| HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3 | 13356-143E8 |
25.45 | 4.44 |
| HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1 | 13333-143C3 |
20.33 | 3.39 |
| HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2 | 13345-143D6 |
43.08 | 8.28 |
| HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3 | 13357-143E9 |
36.82 | 5.52 |
| HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1 | 13334-143C4 |
42.15 | 10.54 |
| HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2 | 13346-143D7 |
32.29 | 10.38 |
| HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3 | 13358-143F1 |
35.86 | 5.22 |
| HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1 | 13335-143C5 |
28.76 | 5.35 |
| HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2 | 13347-143D8 |
37.37 | 8.48 |
| HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3 | 13359-143F2 |
44.16 | 8.90 |
| HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1 | 13336-143C6 |
22.36 | 9.94 |
| HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2 | 13348-143D9 |
32.09 | 7.08 |
| HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3 | 13360-143F3 |
30.17 | 8.45 |
| HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1 | 13337-143C7 |
41.20 | 7.63 |
| HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2 | 13349-143E1 |
30.31 | 9.97 |
| HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3 | 13361-143F4 |
37.00 | 9.37 |
| HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1 | 13338-143C8 |
31.87 | 11.80 |
| HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2 | 13350-143E2 |
36.17 | 14.00 |
| HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3 | 13362-143F5 |
30.28 | 9.66 |
| HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1 | 13339-143C9 |
24.58 | 7.63 |
| HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2 | 13351-143E3 |
26.86 | 4.78 |
| HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3 | 13363-143F6 |
28.63 | 4.37 |
| Hair Follicle Dermal Papilla Cells, donor1 | 11271-116H2 |
17.12 | 2.28 |
| Hair Follicle Dermal Papilla Cells, donor2 | 11348-117G7 |
13.72 | 2.49 |
| Hair Follicle Dermal Papilla Cells, donor3 | 11420-118F7 |
12.37 | 4.50 |
| Hair Follicle Outer Root Sheath Cells, donor1 | 11504-119G1 |
26.64 | 6.98 |
| Hair Follicle Outer Root Sheath Cells, donor2 | 11584-120F9 |
23.81 | 7.10 |
| Hep-2 cells mock treated, biol_rep1 | 11898-125E8 |
20.77 | 2.79 |
| Hep-2 cells mock treated, biol_rep2 | 11899-125E9 |
20.59 | 4.22 |
| Hep-2 cells mock treated, biol_rep3 | 11900-125F1 |
22.07 | 4.32 |
| Hep-2 cells treated with Streptococci strain 5448, biol_rep1 | 11890-125D9 |
22.95 | 3.06 |
| Hep-2 cells treated with Streptococci strain 5448, biol_rep2 | 11891-125E1 |
19.13 | 2.58 |
| Hep-2 cells treated with Streptococci strain 5448, biol_rep3 | 11892-125E2 |
17.87 | 3.44 |
| Hep-2 cells treated with Streptococci strain JRS4, biol_rep1 | 11894-125E4 |
20.92 | 1.99 |
| Hep-2 cells treated with Streptococci strain JRS4, biol_rep2 | 11895-125E5 |
18.18 | 2.57 |
| Hep-2 cells treated with Streptococci strain JRS4, biol_rep3 | 11896-125E6 |
16.02 | 3.20 |
| Hepatic Sinusoidal Endothelial Cells, donor1 | 11521-119H9 |
15.11 | 2.24 |
| Hepatic Sinusoidal Endothelial Cells, donor2 | 11601-120H8 |
8.22 | 1.73 |
| Hepatic Sinusoidal Endothelial Cells, donor3 | 11682-122H8 |
10.58 | 15.86 |
| Hepatic Stellate Cells (lipocyte), donor1 | 11524-119I3 |
14.81 | 3.88 |
| Hepatic Stellate Cells (lipocyte), donor2 | 11604-120I2 |
8.72 | 2.91 |
| Hepatic Stellate Cells (lipocyte), donor3 | 11685-122I2 |
22.20 | 2.10 |
| Hepatocyte, donor1 | 11523-119I2 |
37.53 | 10.90 |
| Hepatocyte, donor2 | 11603-120I1 |
103.42 | 9.70 |
| Hepatocyte, donor3 | 11684-122I1 |
43.56 | 12.88 |
| Hodgkin's lymphoma cell line:HD-Mar2 | 10435-106E3 |
14.36 | 5.22 |
| Intestinal epithelial cells (polarized), donor1 | 11246-116E4 |
61.52 | 7.52 |
| Iris Pigment Epithelial Cells, donor1 | 11530-119I9 |
23.33 | 5.63 |
| K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1 | 13079-140B1 |
28.66 | 3.18 |
| K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2 | 13145-140I4 |
20.03 | 0.00 |
| K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3 | 13211-141G7 |
0.00 | 0.00 |
| K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1 | 13080-140B2 |
16.61 | 0.00 |
| K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2 | 13146-140I5 |
10.01 | 0.00 |
| K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3 | 13212-141G8 |
11.87 | 0.00 |
| K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1 | 13081-140B3 |
20.50 | 0.00 |
| K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2 | 13147-140I6 |
22.85 | 0.00 |
| K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3 | 13213-141G9 |
35.74 | 1.62 |
| K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1 | 13082-140B4 |
23.34 | 1.67 |
| K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2 | 13148-140I7 |
7.26 | 0.00 |
| K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3 | 13214-141H1 |
33.09 | 7.94 |
| K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1 | 13083-140B5 |
13.30 | 5.54 |
| K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2 | 13149-140I8 |
31.43 | 0.00 |
| K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3 | 13215-141H2 |
18.27 | 1.26 |
| K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1 | 13084-140B6 |
13.92 | 1.55 |
| K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2 | 13150-140I9 |
29.27 | 0.00 |
| K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3 | 13216-141H3 |
21.32 | 3.23 |
| K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1 | 13085-140B7 |
25.76 | 0.00 |
| K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2 | 13151-141A1 |
23.90 | 0.00 |
| K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3 | 13217-141H4 |
17.93 | 1.63 |
| K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1 | 13086-140B8 |
18.05 | 3.36 |
| K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2 | 13152-141A2 |
14.37 | 14.37 |
| K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3 | 13218-141H5 |
29.74 | 0.80 |
| K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1 | 13087-140B9 |
19.39 | 0.00 |
| K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2 | 13153-141A3 |
75.40 | 0.00 |
| K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3 | 13219-141H6 |
19.83 | 0.94 |
| K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1 | 13088-140C1 |
21.77 | 1.81 |
| K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2 | 13154-141A4 |
58.97 | 0.00 |
| K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3 | 13220-141H7 |
18.29 | 2.15 |
| K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1 | 13089-140C2 |
33.03 | 5.08 |
| K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2 | 13155-141A5 |
32.86 | 0.00 |
| K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3 | 13221-141H8 |
35.71 | 1.28 |
| K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1 | 13090-140C3 |
34.63 | 3.65 |
| K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2 | 13156-141A6 |
63.22 | 0.00 |
| K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3 | 13222-141H9 |
23.56 | 0.71 |
| K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1 | 13091-140C4 |
43.14 | 3.32 |
| K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2 | 13157-141A7 |
62.55 | 0.00 |
| K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3 | 13223-141I1 |
25.00 | 1.54 |
| K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1 | 13092-140C5 |
35.12 | 1.76 |
| K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2 | 13158-141A8 |
34.57 | 3.14 |
| K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3 | 13224-141I2 |
33.38 | 3.48 |
| K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1 | 13093-140C6 |
28.77 | 0.00 |
| K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2 | 13159-141A9 |
22.69 | 0.00 |
| K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3 | 13225-141I3 |
23.54 | 1.74 |
| K562 erythroblastic leukemia response to hemin, day02, biol_rep1 | 13094-140C7 |
24.75 | 2.25 |
| K562 erythroblastic leukemia response to hemin, day02, biol_rep2 | 13160-141B1 |
38.33 | 0.00 |
| K562 erythroblastic leukemia response to hemin, day02, biol_rep3 | 13226-141I4 |
16.00 | 4.27 |
| K562 erythroblastic leukemia response to hemin, day03, biol_rep1 | 13095-140C8 |
20.78 | 2.77 |
| K562 erythroblastic leukemia response to hemin, day03, biol_rep2 | 13161-141B2 |
28.50 | 2.85 |
| K562 erythroblastic leukemia response to hemin, day03, biol_rep3 | 13227-141I5 |
21.17 | 1.84 |
| K562 erythroblastic leukemia response to hemin, day04, biol_rep1 | 13096-140C9 |
21.18 | 0.00 |
| K562 erythroblastic leukemia response to hemin, day04, biol_rep2 | 13162-141B3 |
31.04 | 0.00 |
| K562 erythroblastic leukemia response to hemin, day04, biol_rep3 | 13228-141I6 |
14.80 | 0.00 |
| Keratinocyte - epidermal, donor1 | 11272-116H3 |
14.04 | 3.02 |
| Keratinocyte - epidermal, donor2 | 11349-117G8 |
2.93 | 0.59 |
| Keratinocyte - epidermal, donor3 | 11421-118F8 |
10.41 | 3.50 |
| Keratinocyte - oral, donor1 | 11251-116E9 |
22.14 | 3.63 |
| Keratocytes, donor1 | 11527-119I6 |
12.03 | 2.41 |
| Keratocytes, donor2 | 11607-120I5 |
7.03 | 2.34 |
| Keratocytes, donor3 | 11688-122I5 |
25.49 | 6.13 |
| Krukenberg tumor cell line:HSKTC | 10687-109F3 |
13.19 | 8.79 |
| Lens Epithelial Cells, donor1 | 11529-119I8 |
25.89 | 7.55 |
| Lens Epithelial Cells, donor2 | 11609-120I7 |
43.36 | 7.50 |
| Lens Epithelial Cells, donor3 | 11690-122I7 |
37.24 | 8.27 |
| Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1) | 12260-130A1 |
13.87 | 3.20 |
| Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1) | 12382-131E6 |
8.37 | 1.67 |
| Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 ) | 12504-133A2 |
22.82 | 3.46 |
| Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2) | 12261-130A2 |
9.68 | 4.30 |
| Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2) | 12383-131E7 |
8.51 | 0.95 |
| Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2) | 12505-133A3 |
8.19 | 1.73 |
| Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3) | 12262-130A3 |
16.01 | 3.69 |
| Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3) | 12384-131E8 |
5.81 | 2.02 |
| Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3) | 12506-133A4 |
9.01 | 2.25 |
| Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4) | 12263-130A4 |
10.28 | 1.58 |
| Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4) | 12385-131E9 |
13.77 | 2.71 |
| Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4) | 12507-133A5 |
4.63 | 1.30 |
| Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5) | 12264-130A5 |
12.19 | 1.74 |
| Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5) | 12386-131F1 |
12.16 | 1.91 |
| Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5) | 12508-133A6 |
8.93 | 1.37 |
| Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6) | 12265-130A6 |
9.55 | 1.85 |
| Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6) | 12387-131F2 |
9.35 | 0.62 |
| Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6) | 12509-133A7 |
8.42 | 1.46 |
| Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7) | 12266-130A7 |
13.16 | 2.30 |
| Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7) | 12388-131F3 |
8.20 | 0.59 |
| Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7) | 12510-133A8 |
9.46 | 1.99 |
| Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8) | 12267-130A8 |
10.18 | 1.94 |
| Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8) | 12389-131F4 |
9.43 | 1.89 |
| Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8) | 12511-133A9 |
9.54 | 1.97 |
| Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9) | 12268-130A9 |
8.29 | 2.07 |
| Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9) | 12390-131F5 |
14.45 | 2.30 |
| Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9) | 12512-133B1 |
9.92 | 1.65 |
| Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10) | 12269-130B1 |
11.01 | 3.44 |
| Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10) | 12391-131F6 |
9.78 | 1.88 |
| Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10) | 12513-133B2 |
7.21 | 2.01 |
| Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11) | 12270-130B2 |
13.57 | 3.88 |
| Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11) | 12392-131F7 |
11.58 | 3.97 |
| Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11) | 12514-133B3 |
7.93 | 1.73 |
| Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12) | 12271-130B3 |
18.14 | 7.03 |
| Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12) | 12393-131F8 |
13.10 | 2.72 |
| Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12) | 12515-133B4 |
7.70 | 1.10 |
| Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13) | 12272-130B4 |
9.01 | 4.50 |
| Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13) | 12394-131F9 |
12.78 | 3.04 |
| Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13) | 12516-133B5 |
13.58 | 3.50 |
| Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14) | 12273-130B5 |
15.64 | 1.78 |
| Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14) | 12395-131G1 |
4.36 | 0.48 |
| Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14) | 12517-133B6 |
6.69 | 2.02 |
| Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15) | 12274-130B6 |
10.39 | 2.86 |
| Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15) | 12396-131G2 |
13.07 | 3.27 |
| Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15) | 12518-133B7 |
6.59 | 1.18 |
| Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16) | 12275-130B7 |
12.87 | 3.84 |
| Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16) | 12397-131G3 |
7.17 | 1.54 |
| Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16) | 12519-133B8 |
8.35 | 2.98 |
| MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1 | 13031-139E7 |
2.27 | 2.27 |
| MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2 | 13097-140D1 |
13.04 | 6.90 |
| MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3 | 13163-141B4 |
4.45 | 5.20 |
| MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1 | 13032-139E8 |
11.00 | 3.39 |
| MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2 | 13098-140D2 |
11.25 | 0.70 |
| MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3 | 13164-141B5 |
7.47 | 6.54 |
| MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1 | 13033-139E9 |
6.70 | 0.52 |
| MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2 | 13099-140D3 |
10.71 | 2.38 |
| MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3 | 13165-141B6 |
7.46 | 3.62 |
| MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1 | 13034-139F1 |
11.05 | 4.07 |
| MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2 | 13100-140D4 |
13.96 | 4.95 |
| MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3 | 13166-141B7 |
14.23 | 2.85 |
| MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1 | 13035-139F2 |
11.81 | 5.14 |
| MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2 | 13101-140D5 |
11.64 | 4.23 |
| MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3 | 13167-141B8 |
12.66 | 4.00 |
| MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1 | 13036-139F3 |
11.72 | 5.09 |
| MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2 | 13102-140D6 |
12.54 | 2.13 |
| MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3 | 13168-141B9 |
13.23 | 4.16 |
| MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1 | 13037-139F4 |
12.88 | 4.29 |
| MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2 | 13103-140D7 |
11.42 | 2.45 |
| MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3 | 13169-141C1 |
11.45 | 4.79 |
| MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1 | 13038-139F5 |
17.38 | 4.48 |
| MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2 | 13104-140D8 |
6.18 | 4.12 |
| MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3 | 13170-141C2 |
14.81 | 4.64 |
| MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1 | 13039-139F6 |
16.74 | 2.99 |
| MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2 | 13105-140D9 |
11.07 | 2.77 |
| MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3 | 13171-141C3 |
13.08 | 4.95 |
| MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1 | 13040-139F7 |
13.64 | 2.95 |
| MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2 | 13106-140E1 |
9.21 | 3.45 |
| MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3 | 13172-141C4 |
15.35 | 7.68 |
| MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1 | 13041-139F8 |
10.19 | 3.96 |
| MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2 | 13107-140E2 |
12.31 | 5.74 |
| MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3 | 13173-141C5 |
13.10 | 4.52 |
| MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1 | 13042-139F9 |
15.80 | 4.31 |
| MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2 | 13108-140E3 |
6.72 | 5.98 |
| MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3 | 13174-141C6 |
10.40 | 5.20 |
| MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1 | 13043-139G1 |
14.21 | 5.60 |
| MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2 | 13109-140E4 |
12.84 | 3.43 |
| MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3 | 13175-141C7 |
10.00 | 2.33 |
| MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1 | 13044-139G2 |
9.65 | 10.26 |
| MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2 | 13110-140E5 |
7.82 | 4.98 |
| MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3 | 13176-141C8 |
13.06 | 3.09 |
| MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1 | 13045-139G3 |
15.57 | 3.22 |
| MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2 | 13111-140E6 |
7.41 | 1.35 |
| MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3 | 13177-141C9 |
11.11 | 4.82 |
| MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1 | 13046-139G4 |
8.14 | 3.49 |
| MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2 | 13112-140E7 |
11.64 | 4.23 |
| MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3 | 13178-141D1 |
11.60 | 4.40 |
| MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1 | 13048-139G6 |
8.72 | 0.73 |
| MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2 | 13114-140E9 |
11.50 | 3.83 |
| MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3 | 13180-141D3 |
9.87 | 5.92 |
| MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1 | 13049-139G7 |
10.35 | 0.00 |
| MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2 | 13115-140F1 |
15.59 | 3.02 |
| MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3 | 13181-141D4 |
10.81 | 4.96 |
| MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1 | 13050-139G8 |
13.77 | 3.44 |
| MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2 | 13116-140F2 |
13.36 | 1.78 |
| MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3 | 13182-141D5 |
15.64 | 3.52 |
| MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1 | 13051-139G9 |
13.85 | 0.66 |
| MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2 | 13117-140F3 |
8.82 | 5.71 |
| MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3 | 13183-141D6 |
10.94 | 1.75 |
| MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1 | 13052-139H1 |
8.95 | 3.91 |
| MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2 | 13118-140F4 |
15.90 | 3.53 |
| MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3 | 13184-141D7 |
10.03 | 3.86 |
| MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1 | 13053-139H2 |
17.22 | 6.08 |
| MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2 | 13119-140F5 |
10.57 | 2.88 |
| MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3 | 13185-141D8 |
13.52 | 3.18 |
| MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1 | 13054-139H3 |
13.98 | 1.82 |
| MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2 | 13120-140F6 |
14.53 | 2.77 |
| MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3 | 13186-141D9 |
9.12 | 1.52 |
| MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1 | 13055-139H4 |
18.07 | 4.65 |
| MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2 | 13121-140F7 |
12.70 | 1.21 |
| MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3 | 13187-141E1 |
13.94 | 4.44 |
| MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1 | 13056-139H5 |
15.99 | 3.73 |
| MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2 | 13122-140F8 |
10.92 | 2.30 |
| MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3 | 13188-141E2 |
11.83 | 1.03 |
| MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1 | 13057-139H6 |
14.15 | 6.37 |
| MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2 | 13123-140F9 |
17.02 | 4.54 |
| MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3 | 13189-141E3 |
15.39 | 4.16 |
| MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1 | 13058-139H7 |
10.18 | 6.26 |
| MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2 | 13124-140G1 |
16.70 | 3.76 |
| MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3 | 13190-141E4 |
7.90 | 3.72 |
| MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1 | 13059-139H8 |
18.73 | 5.35 |
| MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2 | 13125-140G2 |
24.06 | 3.74 |
| MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3 | 13191-141E5 |
12.53 | 4.04 |
| MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1 | 13060-139H9 |
14.68 | 3.67 |
| MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2 | 13126-140G3 |
16.89 | 5.33 |
| MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3 | 13192-141E6 |
15.96 | 3.99 |
| MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1 | 13061-139I1 |
14.57 | 8.44 |
| MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2 | 13127-140G4 |
12.59 | 1.64 |
| MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3 | 13193-141E7 |
10.25 | 3.12 |
| MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1 | 13062-139I2 |
15.08 | 4.16 |
| MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2 | 13128-140G5 |
16.58 | 1.33 |
| MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3 | 13194-141E8 |
12.47 | 6.24 |
| Macrophage - monocyte derived, donor1 | 11232-116C8 |
10.03 | 2.96 |
| Macrophage - monocyte derived, donor2 | 11313-117C8 |
8.07 | 4.22 |
| Macrophage - monocyte derived, donor3 | 11389-118C3 |
14.16 | 3.01 |
| Mallassez-derived cells, donor1 (MZH3) | 12142-128E9 |
9.03 | 3.72 |
| Mallassez-derived cells, donor2 | 11929-125I3 |
20.44 | 5.23 |
| Mallassez-derived cells, donor3 | 11930-125I4 |
17.23 | 3.20 |
| Mammary Epithelial Cell, donor1 | 11273-116H4 |
12.36 | 1.59 |
| Mammary Epithelial Cell, donor2 | 11350-117G9 |
20.85 | 3.19 |
| Mammary Epithelial Cell, donor3 | 11422-118F9 |
6.49 | 0.50 |
| Mast cell - stimulated, donor1 | 11487-119E2 |
25.08 | 3.39 |
| Mast cell, donor1 | 11563-120D6 |
30.60 | 4.11 |
| Mast cell, donor2 | 11565-120D8 |
13.67 | 2.08 |
| Mast cell, donor3 | 11566-120D9 |
10.81 | 2.25 |
| Mast cell, donor4 | 11567-120E1 |
19.50 | 2.48 |
| Mast cell, expanded and stimulated, donor5 | 11940-126A5 |
39.15 | 5.99 |
| Mast cell, expanded and stimulated, donor8 | 11942-126A7 |
56.62 | 8.17 |
| Mast cell, expanded, donor5 | 11939-126A4 |
37.40 | 6.65 |
| Mast cell, expanded, donor8 | 11941-126A6 |
24.94 | 5.19 |
| Melanocyte - dark, donor1 | 11502-119F8 |
17.11 | 4.28 |
| Melanocyte - dark, donor2 | 11582-120F7 |
26.99 | 7.96 |
| Melanocyte - dark, donor3 | 11663-122F7 |
30.21 | 3.77 |
| Melanocyte - light, donor1 | 11274-116H5 |
10.34 | 2.12 |
| Melanocyte - light, donor2 | 11351-117H1 |
10.92 | 1.36 |
| Melanocyte - light, donor3 | 11423-118G1 |
7.81 | 3.47 |
| Melanocyte, donor1 (MC+1) | 12641-134G4 |
20.20 | 3.75 |
| Melanocyte, donor2 (MC+2) | 12739-135I3 |
51.10 | 8.07 |
| Melanocyte, donor3 (MC+3) | 12837-137B2 |
31.61 | 8.57 |
| Meningeal Cells, donor1 | 11493-119E8 |
16.75 | 1.61 |
| Meningeal Cells, donor2 | 11573-120E7 |
13.64 | 4.40 |
| Meningeal Cells, donor3 | 11654-122E7 |
28.28 | 6.76 |
| Mesenchymal Stem Cells - Vertebral, donor1 | 11219-116B4 |
22.53 | 4.85 |
| Mesenchymal Stem Cells - Wharton's Jelly, donor1 | 11548-120B9 |
36.93 | 7.75 |
| Mesenchymal Stem Cells - adipose, donor1 | 11537-120A7 |
7.88 | 0.00 |
| Mesenchymal Stem Cells - adipose, donor2 | 11617-122A6 |
5.23 | 0.00 |
| Mesenchymal Stem Cells - adipose, donor3 | 11698-123A6 |
15.07 | 5.02 |
| Mesenchymal Stem Cells - amniotic membrane, donor1 | 11547-120B8 |
22.66 | 5.93 |
| Mesenchymal Stem Cells - amniotic membrane, donor2 | 11627-122B7 |
18.60 | 3.02 |
| Mesenchymal Stem Cells - bone marrow, donor1 | 11536-120A6 |
17.36 | 3.74 |
| Mesenchymal Stem Cells - bone marrow, donor2 | 11616-122A5 |
9.50 | 0.73 |
| Mesenchymal Stem Cells - bone marrow, donor3 | 11697-123A5 |
14.12 | 2.86 |
| Mesenchymal Stem Cells - bone marrow, donor4 | 11464-119B6 |
25.49 | 5.26 |
| Mesenchymal Stem Cells - hepatic, donor1 | 11538-120A8 |
10.78 | 1.12 |
| Mesenchymal Stem Cells - hepatic, donor2 | 11618-122A7 |
42.89 | 7.37 |
| Mesenchymal Stem Cells - umbilical, donor1 | 11539-120A9 |
10.39 | 2.08 |
| Mesenchymal Stem Cells - umbilical, donor2 | 11619-122A8 |
11.68 | 0.00 |
| Mesenchymal Stem Cells - umbilical, donor3 | 11700-123A8 |
10.89 | 0.64 |
| Mesenchymal stem cells - adipose, donor0 | 11217-116B2 |
17.37 | 1.06 |
| Mesenchymal stem cells - hepatic, donor0 | 11218-116B3 |
30.33 | 7.19 |
| Mesenchymal stem cells - umbilical, donor0 | 11214-116A8 |
40.64 | 10.16 |
| Mesothelial Cells, donor1 | 11247-116E5 |
39.51 | 6.89 |
| Mesothelial Cells, donor2 | 12156-128G5 |
23.52 | 5.00 |
| Mesothelial Cells, donor3 | 11402-118D7 |
31.00 | 5.28 |
| Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1) | 12698-135D7 |
1.35 | 0.00 |
| Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2) | 12796-136F6 |
9.85 | 2.96 |
| Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3) | 12894-137H5 |
8.83 | 2.36 |
| Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1) | 12699-135D8 |
6.91 | 0.00 |
| Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2) | 12797-136F7 |
6.82 | 1.24 |
| Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3) | 12895-137H6 |
5.81 | 2.70 |
| Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1) | 12700-135D9 |
2.32 | 2.32 |
| Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2) | 12798-136F8 |
7.01 | 3.75 |
| Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3) | 12896-137H7 |
6.52 | 0.93 |
| Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1) | 12701-135E1 |
19.47 | 0.00 |
| Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2) | 12799-136F9 |
8.94 | 1.83 |
| Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3) | 12897-137H8 |
9.50 | 1.58 |
| Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1) | 12702-135E2 |
0.00 | 0.00 |
| Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2) | 12800-136G1 |
3.54 | 0.88 |
| Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3) | 12898-137H9 |
5.70 | 3.42 |
| Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1) | 12703-135E3 |
5.26 | 2.63 |
| Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2) | 12801-136G2 |
8.06 | 2.33 |
| Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3) | 12899-137I1 |
3.68 | 0.92 |
| Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1) | 12704-135E4 |
0.00 | 0.00 |
| Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2) | 12802-136G3 |
4.77 | 2.09 |
| Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3) | 12900-137I2 |
3.35 | 0.00 |
| Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1) | 12705-135E5 |
0.00 | 0.00 |
| Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2) | 12803-136G4 |
4.52 | 2.51 |
| Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3) | 12901-137I3 |
6.89 | 1.90 |
| Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1) | 12706-135E6 |
3.32 | 1.11 |
| Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2) | 12804-136G5 |
4.14 | 1.38 |
| Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3) | 12902-137I4 |
5.47 | 1.47 |
| Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1) | 12707-135E7 |
3.67 | 1.83 |
| Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2) | 12805-136G6 |
4.72 | 0.86 |
| Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3) | 12903-137I5 |
4.22 | 1.56 |
| Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1) | 12708-135E8 |
0.00 | 0.00 |
| Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2) | 12806-136G7 |
2.19 | 1.10 |
| Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3) | 12904-137I6 |
2.03 | 0.00 |
| Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1) | 12709-135E9 |
0.00 | 1.66 |
| Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2) | 12807-136G8 |
1.09 | 0.82 |
| Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3) | 12905-137I7 |
5.00 | 1.18 |
| Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1) | 12710-135F1 |
0.00 | 0.00 |
| Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2) | 12808-136G9 |
1.92 | 0.96 |
| Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3) | 12906-137I8 |
5.20 | 3.20 |
| Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1) | 12711-135F2 |
2.74 | 0.00 |
| Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2) | 12809-136H1 |
3.50 | 1.00 |
| Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3) | 12907-137I9 |
0.00 | 26.95 |
| Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1) | 12712-135F3 |
0.00 | 0.00 |
| Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2) | 12810-136H2 |
4.82 | 0.88 |
| Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3) | 12908-138A1 |
2.21 | 0.00 |
| Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1) | 12713-135F4 |
2.56 | 4.48 |
| Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2) | 12811-136H3 |
3.72 | 2.23 |
| Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3) | 12909-138A2 |
4.18 | 0.70 |
| Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1) | 12714-135F5 |
0.00 | 4.42 |
| Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2) | 12812-136H4 |
8.21 | 0.68 |
| Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3) | 12910-138A3 |
1.75 | 2.19 |
| Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1) | 12715-135F6 |
3.55 | 1.42 |
| Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2) | 12813-136H5 |
9.54 | 2.24 |
| Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3) | 12911-138A4 |
7.07 | 2.08 |
| Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1) | 12716-135F7 |
5.83 | 0.58 |
| Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2) | 12814-136H6 |
3.62 | 4.22 |
| Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3) | 12912-138A5 |
11.69 | 2.92 |
| Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1) | 12717-135F8 |
0.00 | 7.22 |
| Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2) | 12815-136H7 |
9.24 | 2.77 |
| Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3) | 12913-138A6 |
7.40 | 2.28 |
| Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1) | 12718-135F9 |
6.36 | 1.11 |
| Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2) | 12816-136H8 |
9.59 | 4.15 |
| Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3) | 12914-138A7 |
6.01 | 1.29 |
| Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1) | 12719-135G1 |
7.62 | 3.18 |
| Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2) | 12817-136H9 |
8.01 | 1.87 |
| Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3) | 12915-138A8 |
12.27 | 2.99 |
| Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1) | 12720-135G2 |
6.22 | 2.12 |
| Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2) | 12818-136I1 |
12.10 | 3.19 |
| Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3) | 12916-138A9 |
10.61 | 2.65 |
| Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1) | 12721-135G3 |
5.31 | 0.76 |
| Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2) | 12819-136I2 |
11.36 | 3.41 |
| Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3) | 12917-138B1 |
15.73 | 2.95 |
| Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1) | 12722-135G4 |
11.73 | 2.61 |
| Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2) | 12820-136I3 |
10.88 | 3.53 |
| Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3) | 12918-138B2 |
15.28 | 2.59 |
| Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1) | 12723-135G5 |
11.13 | 1.65 |
| Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2) | 12821-136I4 |
16.08 | 3.57 |
| Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h) | 13304-142I1 |
0.00 | 11.30 |
| Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h) | 13316-143A4 |
12.48 | 3.56 |
| Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h) | 13322-143B1 |
13.80 | 4.93 |
| Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h) | 13310-142I7 |
8.42 | 4.21 |
| Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h) | 13309-142I6 |
13.24 | 2.57 |
| Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h) | 13321-143A9 |
3.73 | 4.66 |
| Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h) | 13327-143B6 |
10.51 | 5.26 |
| Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h) | 13315-143A3 |
7.19 | 3.73 |
| Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h) | 13305-142I2 |
10.07 | 3.17 |
| Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h) | 13317-143A5 |
2.21 | 2.21 |
| Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h) | 13323-143B2 |
12.09 | 3.30 |
| Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h) | 13311-142I8 |
9.33 | 0.00 |
| Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h) | 13306-142I3 |
0.53 | 1.07 |
| Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h) | 13318-143A6 |
0.00 | 0.00 |
| Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h) | 13324-143B3 |
14.14 | 5.05 |
| Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h) | 13312-142I9 |
2.95 | 1.26 |
| Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h) | 13307-142I4 |
1.36 | 0.00 |
| Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h) | 13319-143A7 |
0.00 | 0.00 |
| Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h) | 13325-143B4 |
3.24 | 1.62 |
| Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h) | 13313-143A1 |
12.08 | 1.51 |
| Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h) | 13308-142I5 |
11.42 | 0.00 |
| Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h) | 13320-143A8 |
9.79 | 0.00 |
| Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h) | 13326-143B5 |
0.00 | 0.00 |
| Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h) | 13314-143A2 |
37.65 | 0.00 |
| Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1 | 11549-120C1 |
21.33 | 4.74 |
| Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2 | 11629-122B9 |
13.07 | 5.23 |
| Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1 | 13496-145C4 |
36.71 | 9.34 |
| Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2 | 13505-145D4 |
14.19 | 3.34 |
| Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3 | 13514-145E4 |
5.70 | 4.37 |
| Myoblast differentiation to myotubes, day00, control donor1 | 13469-144I4 |
31.92 | 1.60 |
| Myoblast differentiation to myotubes, day00, control donor2 | 13478-145A4 |
29.24 | 8.16 |
| Myoblast differentiation to myotubes, day00, control donor3 | 13487-145B4 |
3.68 | 0.00 |
| Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1 | 13497-145C5 |
28.04 | 5.44 |
| Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2 | 13506-145D5 |
12.78 | 8.83 |
| Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3 | 13515-145E5 |
17.56 | 9.19 |
| Myoblast differentiation to myotubes, day01, control donor1 | 13470-144I5 |
22.92 | 6.10 |
| Myoblast differentiation to myotubes, day01, control donor2 | 13479-145A5 |
0.00 | 0.00 |
| Myoblast differentiation to myotubes, day01, control donor3 | 13488-145B5 |
18.86 | 6.45 |
| Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1 | 13498-145C6 |
9.74 | 4.33 |
| Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2 | 13507-145D6 |
21.08 | 3.85 |
| Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3 | 13516-145E6 |
21.88 | 9.47 |
| Myoblast differentiation to myotubes, day02, control donor1 | 13471-144I6 |
13.49 | 3.83 |
| Myoblast differentiation to myotubes, day02, control donor2 | 13480-145A6 |
28.11 | 10.61 |
| Myoblast differentiation to myotubes, day02, control donor3 | 13489-145B6 |
21.61 | 6.60 |
| Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1 | 13499-145C7 |
6.24 | 1.31 |
| Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2 | 13508-145D7 |
18.54 | 5.04 |
| Myoblast differentiation to myotubes, day03, control donor1 | 13472-144I7 |
15.70 | 4.06 |
| Myoblast differentiation to myotubes, day03, control donor2 | 13481-145A7 |
29.54 | 9.14 |
| Myoblast differentiation to myotubes, day03, control donor3 | 13490-145B7 |
13.33 | 10.57 |
| Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1 | 13500-145C8 |
31.17 | 9.64 |
| Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2 | 13509-145D8 |
4.48 | 2.41 |
| Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3 | 13518-145E8 |
2.53 | 5.06 |
| Myoblast differentiation to myotubes, day04, control donor1 | 13473-144I8 |
11.81 | 2.90 |
| Myoblast differentiation to myotubes, day04, control donor2 | 13482-145A8 |
13.97 | 7.20 |
| Myoblast differentiation to myotubes, day04, control donor3 | 13491-145B8 |
9.97 | 6.17 |
| Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1 | 13501-145C9 |
35.63 | 11.16 |
| Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2 | 13510-145D9 |
9.03 | 9.03 |
| Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3 | 13519-145E9 |
25.99 | 7.00 |
| Myoblast differentiation to myotubes, day06, control donor1 | 13474-144I9 |
13.98 | 2.71 |
| Myoblast differentiation to myotubes, day06, control donor2 | 13483-145A9 |
22.22 | 9.52 |
| Myoblast differentiation to myotubes, day06, control donor3 | 13492-145B9 |
25.07 | 9.29 |
| Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1 | 13502-145D1 |
14.76 | 5.30 |
| Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2 | 13511-145E1 |
23.14 | 6.52 |
| Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3 | 13520-145F1 |
30.50 | 8.72 |
| Myoblast differentiation to myotubes, day08, control donor1 | 13475-145A1 |
12.21 | 5.88 |
| Myoblast differentiation to myotubes, day08, control donor2 | 13484-145B1 |
22.93 | 10.58 |
| Myoblast differentiation to myotubes, day08, control donor3 | 13493-145C1 |
31.25 | 12.63 |
| Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1 | 13503-145D2 |
24.31 | 3.47 |
| Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2 | 13512-145E2 |
21.44 | 8.04 |
| Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3 | 13521-145F2 |
26.92 | 12.70 |
| Myoblast differentiation to myotubes, day10, control donor1 | 13476-145A2 |
15.25 | 3.09 |
| Myoblast differentiation to myotubes, day10, control donor2 | 13485-145B2 |
38.63 | 13.55 |
| Myoblast differentiation to myotubes, day10, control donor3 | 13494-145C2 |
5.11 | 15.33 |
| Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1 | 13504-145D3 |
28.66 | 10.36 |
| Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2 | 13513-145E3 |
11.65 | 8.18 |
| Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3 | 13522-145F3 |
19.37 | 8.47 |
| Myoblast differentiation to myotubes, day12, control donor1 | 13477-145A3 |
26.90 | 4.75 |
| Myoblast differentiation to myotubes, day12, control donor2 | 13486-145B3 |
2.27 | 3.40 |
| Myoblast differentiation to myotubes, day12, control donor3 | 13495-145C3 |
5.06 | 10.12 |
| Myoblast, donor1 | 11241-116D8 |
19.13 | 5.96 |
| Myoblast, donor2 | 11322-117D8 |
24.17 | 6.71 |
| Myoblast, donor3 | 11398-118D3 |
19.68 | 6.56 |
| NK T cell leukemia cell line:KHYG-1 | 10777-110G3 |
18.83 | 3.79 |
| Natural Killer Cells, donor1 | 11230-116C6 |
8.30 | 1.54 |
| Natural Killer Cells, donor2 | 11311-117C6 |
4.52 | 1.21 |
| Natural Killer Cells, donor3 | 11387-118C1 |
4.05 | 0.92 |
| Neural stem cells, donor1 | 11275-116H6 |
46.82 | 11.98 |
| Neural stem cells, donor2 | 11352-117H2 |
13.48 | 9.63 |
| Neurons, donor1 | 11494-119E9 |
15.93 | 11.38 |
| Neurons, donor2 | 11574-120E8 |
28.84 | 9.03 |
| Neurons, donor3 | 11655-122E8 |
27.13 | 6.58 |
| Neutrophils, donor1 | 11233-116C9 |
0.00 | 0.93 |
| Neutrophils, donor2 | 11314-117C9 |
2.90 | 0.00 |
| Neutrophils, donor3 | 11390-118C4 |
0.00 | 0.61 |
| Nucleus Pulposus Cell, donor1 | 11252-116F1 |
31.11 | 8.07 |
| Nucleus Pulposus Cell, donor2 | 11409-118E5 |
19.21 | 4.23 |
| Nucleus Pulposus Cell, donor3 | 11462-119B4 |
20.26 | 2.61 |
| Olfactory epithelial cells, donor1 | 11933-125I7 |
11.56 | 3.85 |
| Olfactory epithelial cells, donor2 | 11934-125I8 |
16.21 | 4.92 |
| Olfactory epithelial cells, donor3 | 11935-125I9 |
15.78 | 3.97 |
| Olfactory epithelial cells, donor4 | 11936-126A1 |
20.45 | 4.19 |
| Oligodendrocyte - precursors, donor1 | 11496-119F2 |
24.67 | 3.61 |
| Osteoblast - differentiated, donor1 | 11276-116H7 |
13.19 | 3.40 |
| Osteoblast - differentiated, donor2 | 11353-117H3 |
5.72 | 5.72 |
| Osteoblast - differentiated, donor3 | 11425-118G3 |
12.41 | 0.62 |
| Osteoblast, donor1 | 11277-116H8 |
5.08 | 1.56 |
| Osteoblast, donor2 | 11354-117H4 |
35.12 | 7.73 |
| Osteoblast, donor3 | 11426-118G4 |
17.42 | 4.80 |
| Pancreatic stromal cells, donor1 | 11249-116E7 |
21.99 | 5.31 |
| Pericytes, donor1 | 11491-119E6 |
6.79 | 1.45 |
| Pericytes, donor2 | 11571-120E5 |
9.51 | 2.94 |
| Pericytes, donor3 | 11652-122E5 |
14.44 | 2.85 |
| Perineurial Cells, donor1 | 11499-119F5 |
24.07 | 5.54 |
| Perineurial Cells, donor2 | 11579-120F4 |
31.65 | 6.26 |
| Peripheral Blood Mononuclear Cells, donor1 | 11231-116C7 |
8.29 | 0.96 |
| Peripheral Blood Mononuclear Cells, donor2 | 11312-117C7 |
3.92 | 0.73 |
| Peripheral Blood Mononuclear Cells, donor3 | 11388-118C2 |
3.36 | 0.65 |
| Placental Epithelial Cells, donor1 | 11278-116H9 |
6.46 | 0.48 |
| Placental Epithelial Cells, donor2 | 11355-117H5 |
9.98 | 0.00 |
| Placental Epithelial Cells, donor3 | 11427-118G5 |
10.01 | 2.75 |
| Preadipocyte - breast donor2 (cytoplasmic fraction) | 14319-155D8 |
12.03 | 3.80 |
| Preadipocyte - breast, donor1 | 11467-119B9 |
26.83 | 3.38 |
| Preadipocyte - breast, donor2 (nuclear fraction) | 14320-155D9 |
21.80 | 8.75 |
| Preadipocyte - breast, donor2 | 11328-117E5 |
20.49 | 6.08 |
| Preadipocyte - omental, donor1 | 11468-119C1 |
31.86 | 5.22 |
| Preadipocyte - omental, donor2 | 11329-117E6 |
27.93 | 4.36 |
| Preadipocyte - omental, donor3 | 11403-118D8 |
27.22 | 5.87 |
| Preadipocyte - perirenal, donor1 | 11469-119C2 |
17.72 | 1.97 |
| Preadipocyte - subcutaneous, donor1 | 11279-116I1 |
18.73 | 2.15 |
| Preadipocyte - subcutaneous, donor2 | 11356-117H6 |
36.30 | 7.08 |
| Preadipocyte - subcutaneous, donor3 | 11428-118G6 |
25.03 | 6.98 |
| Preadipocyte - visceral, donor1 | 11280-116I2 |
40.89 | 5.50 |
| Preadipocyte - visceral, donor2 | 11357-117H7 |
40.96 | 4.14 |
| Preadipocyte - visceral, donor3 | 11429-118G7 |
28.32 | 5.02 |
| Prostate Epithelial Cells (polarized), donor1 | 11253-116F2 |
50.69 | 8.75 |
| Prostate Epithelial Cells, donor2 | 11331-117E8 |
19.36 | 5.28 |
| Prostate Epithelial Cells, donor3 | 11404-118D9 |
10.47 | 3.12 |
| Prostate Stromal Cells, donor1 | 11254-116F3 |
37.36 | 7.63 |
| Prostate Stromal Cells, donor2 | 11332-117E9 |
25.82 | 3.59 |
| Prostate Stromal Cells, donor3 | 11405-118E1 |
21.69 | 5.84 |
| Renal Cortical Epithelial Cells, donor1 | 11516-119H4 |
4.01 | 0.73 |
| Renal Cortical Epithelial Cells, donor2 | 11596-120H3 |
18.71 | 4.37 |
| Renal Epithelial Cells, donor1 | 11517-119H5 |
7.10 | 1.01 |
| Renal Epithelial Cells, donor2 | 11597-120H4 |
4.27 | 2.13 |
| Renal Epithelial Cells, donor3 | 11678-122H4 |
37.69 | 8.26 |
| Renal Glomerular Endothelial Cells, donor1 | 11514-119H2 |
13.62 | 2.04 |
| Renal Glomerular Endothelial Cells, donor2 | 11594-120H1 |
17.12 | 2.56 |
| Renal Glomerular Endothelial Cells, donor3 | 11675-122H1 |
29.31 | 6.22 |
| Renal Glomerular Endothelial Cells, donor4 | 11783-124B1 |
3.99 | 2.00 |
| Renal Mesangial Cells, donor1 | 11518-119H6 |
15.19 | 1.76 |
| Renal Mesangial Cells, donor2 | 11598-120H5 |
9.40 | 1.25 |
| Renal Mesangial Cells, donor3 | 11679-122H5 |
4.99 | 0.83 |
| Renal Proximal Tubular Epithelial Cell, donor1 | 11515-119H3 |
18.25 | 2.68 |
| Renal Proximal Tubular Epithelial Cell, donor2 | 11595-120H2 |
7.17 | 2.11 |
| Renal Proximal Tubular Epithelial Cell, donor3 | 11676-122H2 |
11.19 | 1.93 |
| Retinal Pigment Epithelial Cells, donor0 | 11215-116A9 |
17.37 | 6.74 |
| Retinal Pigment Epithelial Cells, donor1 | 11528-119I7 |
16.49 | 3.98 |
| Retinal Pigment Epithelial Cells, donor2 | 11608-120I6 |
7.20 | 2.06 |
| Retinal Pigment Epithelial Cells, donor3 | 11689-122I6 |
35.88 | 7.03 |
| SABiosciences XpressRef Human Universal Total RNA, pool1 | 10002-101A5 |
46.10 | 7.08 |
| Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17) | 12697-135D6 |
25.02 | 4.47 |
| Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17) | 12795-136F5 |
15.41 | 4.40 |
| Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17) | 12893-137H4 |
9.86 | 4.06 |
| Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0) | 12662-134I7 |
14.43 | 2.34 |
| Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0) | 12760-136B6 |
18.47 | 2.58 |
| Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0) | 12858-137D5 |
24.43 | 4.24 |
| Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1) | 12663-134I8 |
16.75 | 2.23 |
| Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1) | 12761-136B7 |
17.71 | 3.15 |
| Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1) | 12859-137D6 |
18.72 | 3.70 |
| Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2) | 12664-134I9 |
17.11 | 1.64 |
| Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2) | 12762-136B8 |
15.28 | 2.72 |
| Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2) | 12860-137D7 |
18.81 | 3.05 |
| Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3) | 12665-135A1 |
17.50 | 2.58 |
| Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3) | 12763-136B9 |
15.35 | 2.36 |
| Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3) | 12861-137D8 |
17.26 | 3.76 |
| Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4) | 12666-135A2 |
16.63 | 2.49 |
| Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4) | 12764-136C1 |
15.47 | 2.79 |
| Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4) | 12862-137D9 |
21.80 | 4.51 |
| Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5) | 12667-135A3 |
19.11 | 1.99 |
| Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5) | 12765-136C2 |
13.53 | 2.82 |
| Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5) | 12863-137E1 |
20.24 | 3.25 |
| Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6) | 12668-135A4 |
16.77 | 2.88 |
| Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6) | 12766-136C3 |
15.98 | 1.68 |
| Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6) | 12864-137E2 |
17.09 | 3.08 |
| Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7) | 12669-135A5 |
18.05 | 3.28 |
| Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7) | 12767-136C4 |
15.45 | 3.07 |
| Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7) | 12865-137E3 |
17.33 | 3.63 |
| Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8) | 12670-135A6 |
25.24 | 2.83 |
| Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8) | 12768-136C5 |
15.08 | 2.18 |
| Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8) | 12866-137E4 |
20.58 | 3.04 |
| Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9) | 12671-135A7 |
21.56 | 3.94 |
| Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9) | 12769-136C6 |
16.15 | 3.76 |
| Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9) | 12867-137E5 |
16.50 | 2.51 |
| Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10) | 12672-135A8 |
24.63 | 2.96 |
| Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10) | 12770-136C7 |
15.50 | 2.21 |
| Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10) | 12868-137E6 |
23.14 | 3.86 |
| Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11) | 12673-135A9 |
23.04 | 3.09 |
| Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11) | 12771-136C8 |
17.15 | 3.98 |
| Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11) | 12869-137E7 |
22.82 | 4.10 |
| Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12) | 12674-135B1 |
20.11 | 2.39 |
| Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12) | 12772-136C9 |
16.87 | 3.99 |
| Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12) | 12870-137E8 |
19.46 | 4.00 |
| Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13) | 12675-135B2 |
25.72 | 2.21 |
| Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13) | 12773-136D1 |
16.19 | 3.10 |
| Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13) | 12871-137E9 |
24.18 | 4.43 |
| Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14) | 12676-135B3 |
18.36 | 2.35 |
| Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14) | 12774-136D2 |
18.17 | 3.84 |
| Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14) | 12872-137F1 |
10.88 | 1.81 |
| Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15) | 12677-135B4 |
19.83 | 2.57 |
| Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15) | 12775-136D3 |
34.35 | 6.11 |
| Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15) | 12873-137F2 |
12.17 | 4.87 |
| Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16) | 12678-135B5 |
20.19 | 2.41 |
| Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16) | 12776-136D4 |
29.63 | 6.11 |
| Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16) | 12874-137F3 |
30.55 | 5.69 |
| Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17) | 12679-135B6 |
21.37 | 3.54 |
| Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17) | 12777-136D5 |
31.59 | 4.70 |
| Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17) | 12875-137F4 |
25.84 | 3.00 |
| Schwann Cells, donor1 | 11498-119F4 |
7.15 | 1.69 |
| Schwann Cells, donor2 | 11578-120F3 |
20.41 | 10.21 |
| Schwann Cells, donor3 | 11659-122F3 |
22.13 | 5.26 |
| Sebocyte, donor1 | 11220-116B5 |
14.79 | 6.03 |
| Sebocyte, donor2 | 11301-117B5 |
11.95 | 1.84 |
| Sebocyte, donor3 | 11378-118B1 |
9.48 | 1.44 |
| Sertoli Cells, donor1 | 11255-116F4 |
41.41 | 13.25 |
| Sertoli Cells, donor2 | 11333-117F1 |
28.24 | 0.00 |
| Skeletal Muscle Cells, donor1 | 11281-116I3 |
21.73 | 3.96 |
| Skeletal Muscle Cells, donor2 | 11358-117H8 |
5.06 | 2.17 |
| Skeletal Muscle Cells, donor3 | 11430-118G8 |
13.38 | 5.02 |
| Skeletal Muscle Cells, donor4 | 11451-119A2 |
22.62 | 2.51 |
| Skeletal Muscle Cells, donor5 | 11455-119A6 |
23.04 | 2.23 |
| Skeletal Muscle Cells, donor6 | 11459-119B1 |
20.78 | 4.00 |
| Skeletal Muscle Satellite Cells, donor1 | 11240-116D7 |
24.95 | 5.80 |
| Skeletal Muscle Satellite Cells, donor2 | 11321-117D7 |
23.97 | 3.85 |
| Skeletal Muscle Satellite Cells, donor3 | 11397-118D2 |
22.02 | 4.46 |
| Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1 | 11282-116I4 |
14.32 | 3.71 |
| Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2 | 11359-117H9 |
3.62 | 3.62 |
| Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3 | 11431-118G9 |
11.01 | 3.03 |
| Skin - palm, donor1 | 10286-104F7 |
13.43 | 0.00 |
| Small Airway Epithelial Cells donor2 (cytoplasmic fraction) | 14334-155F5 |
16.00 | 5.48 |
| Small Airway Epithelial Cells donor2 (nuclear fraction) | 14335-155F6 |
24.54 | 5.73 |
| Small Airway Epithelial Cells donor3 (cytoplasmic fraction) | 14316-155D5 |
13.11 | 2.99 |
| Small Airway Epithelial Cells, donor1 | 11256-116F5 |
15.43 | 2.92 |
| Small Airway Epithelial Cells, donor2 | 11334-117F2 |
7.60 | 2.53 |
| Small Airway Epithelial Cells, donor3 (nuclear fraction) | 14317-155D6 |
32.77 | 5.29 |
| Small Airway Epithelial Cells, donor3 | 11406-118E2 |
15.36 | 3.07 |
| Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction) | 14313-155D2 |
2.16 | 0.62 |
| Smooth Muscle Cells - Aortic, donor0 (nuclear fraction) | 14314-155D3 |
85.15 | 15.34 |
| Smooth Muscle Cells - Aortic, donor0 | 11210-116A4 |
17.63 | 1.18 |
| Smooth Muscle Cells - Aortic, donor1 | 11283-116I5 |
23.65 | 3.31 |
| Smooth Muscle Cells - Aortic, donor2 | 11360-117I1 |
10.63 | 2.76 |
| Smooth Muscle Cells - Aortic, donor3 | 11432-118H1 |
14.68 | 3.86 |
| Smooth Muscle Cells - Bladder, donor1 | 11519-119H7 |
32.02 | 8.01 |
| Smooth Muscle Cells - Brachiocephalic, donor1 | 11284-116I6 |
11.71 | 3.59 |
| Smooth Muscle Cells - Brachiocephalic, donor2 | 11361-117I2 |
35.69 | 7.98 |
| Smooth Muscle Cells - Brachiocephalic, donor3 | 11433-118H2 |
26.12 | 5.12 |
| Smooth Muscle Cells - Brain Vascular, donor1 | 11234-116D1 |
18.23 | 2.93 |
| Smooth Muscle Cells - Brain Vascular, donor2 | 11315-117D1 |
24.51 | 3.54 |
| Smooth Muscle Cells - Brain Vascular, donor3 | 11391-118C5 |
27.62 | 4.98 |
| Smooth Muscle Cells - Bronchial, donor1 | 11512-119G9 |
8.30 | 1.95 |
| Smooth Muscle Cells - Bronchial, donor2 | 11592-120G8 |
22.53 | 7.92 |
| Smooth Muscle Cells - Carotid, donor1 | 11285-116I7 |
12.88 | 3.54 |
| Smooth Muscle Cells - Carotid, donor2 | 11362-117I3 |
0.00 | 0.00 |
| Smooth Muscle Cells - Carotid, donor3 | 11434-118H3 |
7.15 | 1.91 |
| Smooth Muscle Cells - Colonic, donor1 | 11239-116D6 |
28.76 | 4.42 |
| Smooth Muscle Cells - Colonic, donor2 | 11320-117D6 |
28.41 | 6.03 |
| Smooth Muscle Cells - Colonic, donor3 | 11396-118D1 |
24.46 | 4.30 |
| Smooth Muscle Cells - Coronary Artery, donor1 | 11286-116I8 |
12.68 | 2.17 |
| Smooth Muscle Cells - Coronary Artery, donor2 | 11363-117I4 |
26.95 | 2.16 |
| Smooth Muscle Cells - Coronary Artery, donor3 | 11435-118H4 |
19.72 | 5.38 |
| Smooth Muscle Cells - Esophageal, donor1 | 11508-119G5 |
7.17 | 1.71 |
| Smooth Muscle Cells - Esophageal, donor2 | 11588-120G4 |
32.51 | 8.48 |
| Smooth Muscle Cells - Internal Thoracic Artery, donor1 | 11287-116I9 |
31.20 | 6.74 |
| Smooth Muscle Cells - Internal Thoracic Artery, donor2 | 11364-117I5 |
76.00 | 11.61 |
| Smooth Muscle Cells - Internal Thoracic Artery, donor3 | 11436-118H5 |
15.10 | 2.42 |
| Smooth Muscle Cells - Intestinal, donor1 | 11509-119G6 |
38.68 | 5.56 |
| Smooth Muscle Cells - Prostate, donor1 | 11257-116F6 |
29.96 | 3.99 |
| Smooth Muscle Cells - Prostate, donor2 | 11335-117F3 |
37.69 | 5.76 |
| Smooth Muscle Cells - Prostate, donor3 | 11465-119B7 |
10.40 | 3.55 |
| Smooth Muscle Cells - Pulmonary Artery, donor1 | 11288-117A1 |
36.49 | 5.28 |
| Smooth Muscle Cells - Pulmonary Artery, donor2 | 11365-117I6 |
16.50 | 5.25 |
| Smooth Muscle Cells - Pulmonary Artery, donor3 | 11437-118H6 |
3.88 | 0.00 |
| Smooth Muscle Cells - Subclavian Artery, donor1 | 11289-117A2 |
17.21 | 4.19 |
| Smooth Muscle Cells - Subclavian Artery, donor2 | 11366-117I7 |
29.28 | 4.54 |
| Smooth Muscle Cells - Subclavian Artery, donor3 | 11438-118H7 |
31.34 | 3.13 |
| Smooth Muscle Cells - Tracheal, donor1 | 11513-119H1 |
7.37 | 1.47 |
| Smooth Muscle Cells - Tracheal, donor2 | 11593-120G9 |
29.91 | 5.25 |
| Smooth Muscle Cells - Tracheal, donor3 | 11674-122G9 |
14.01 | 6.07 |
| Smooth Muscle Cells - Umbilical Artery, donor1 | 11290-117A3 |
11.08 | 2.45 |
| Smooth Muscle Cells - Umbilical Artery, donor2 | 11367-117I8 |
7.65 | 3.57 |
| Smooth Muscle Cells - Umbilical Artery, donor3 | 11439-118H8 |
9.03 | 1.32 |
| Smooth Muscle Cells - Umbilical Vein, donor1 | 11541-120B2 |
23.34 | 3.63 |
| Smooth Muscle Cells - Umbilical Vein, donor2 | 11621-122B1 |
24.47 | 5.11 |
| Smooth Muscle Cells - Umbilical Vein, donor3 | 11702-123B1 |
4.29 | 0.48 |
| Smooth Muscle Cells - Umbilical artery, donor0 | 11212-116A6 |
9.79 | 2.94 |
| Smooth Muscle Cells - Uterine, donor1 | 11258-116F7 |
37.34 | 5.08 |
| Smooth Muscle Cells - Uterine, donor3 | 11466-119B8 |
12.00 | 2.93 |
| Smooth muscle cells - airway, asthmatic, donor1 | 11960-126C7 |
16.33 | 4.47 |
| Smooth muscle cells - airway, asthmatic, donor2 | 11961-126C8 |
12.96 | 2.91 |
| Smooth muscle cells - airway, asthmatic, donor3 | 11962-126C9 |
10.41 | 2.98 |
| Smooth muscle cells - airway, asthmatic, donor4 | 11963-126D1 |
23.72 | 6.83 |
| Smooth muscle cells - airway, asthmatic, donor5 | 11964-126D2 |
19.02 | 3.97 |
| Smooth muscle cells - airway, asthmatic, donor6 | 11965-126D3 |
17.33 | 4.73 |
| Smooth muscle cells - airway, control, donor1 | 11966-126D4 |
15.24 | 3.56 |
| Smooth muscle cells - airway, control, donor2 | 11967-126D5 |
17.97 | 2.40 |
| Smooth muscle cells - airway, control, donor3 | 11968-126D6 |
19.65 | 5.85 |
| Smooth muscle cells - airway, control, donor4 | 11969-126D7 |
18.33 | 5.96 |
| Synoviocyte, donor1 | 11291-117A4 |
25.25 | 4.71 |
| Synoviocyte, donor2 | 11368-117I9 |
27.32 | 5.70 |
| Synoviocyte, donor3 | 11440-118H9 |
14.75 | 4.02 |
| Trabecular Meshwork Cells, donor1 | 11532-120A2 |
11.43 | 0.00 |
| Trabecular Meshwork Cells, donor2 | 11612-122A1 |
5.95 | 0.00 |
| Trabecular Meshwork Cells, donor3 | 11693-123A1 |
7.64 | 0.93 |
| Tracheal Epithelial Cells, donor1 | 11292-117A5 |
8.67 | 1.22 |
| Tracheal Epithelial Cells, donor2 | 11369-118A1 |
8.12 | 1.16 |
| Tracheal Epithelial Cells, donor3 | 11441-118I1 |
7.44 | 0.57 |
| Universal RNA - Human Normal Tissues Biochain, pool1 | 10007-101B4 |
47.73 | 8.73 |
| Urethra, donor2 | 10319-105A4 |
19.78 | 3.60 |
| Urothelial Cells, donor1 | 11520-119H8 |
8.77 | 2.39 |
| Urothelial Cells, donor2 | 11600-120H7 |
3.20 | 1.20 |
| Urothelial Cells, donor3 | 11681-122H7 |
5.27 | 1.38 |
| Urothelial cells, donor0 | 11216-116B1 |
24.74 | 4.46 |
| Whole blood (ribopure), donor090309, donation1 | 12179-129A1 |
10.68 | 3.56 |
| Whole blood (ribopure), donor090309, donation2 | 12180-129A2 |
18.58 | 5.72 |
| Whole blood (ribopure), donor090309, donation3 | 12181-129A3 |
10.27 | 0.68 |
| Whole blood (ribopure), donor090325, donation1 | 12176-128I7 |
12.05 | 3.79 |
| Whole blood (ribopure), donor090325, donation2 | 12177-128I8 |
12.78 | 1.74 |
| Whole blood (ribopure), donor090612, donation1 | 12182-129A4 |
16.66 | 2.08 |
| Whole blood (ribopure), donor090612, donation2 | 12183-129A5 |
10.10 | 0.92 |
| Whole blood (ribopure), donor090612, donation3 | 12184-129A6 |
8.22 | 0.91 |
| Wilms' tumor cell line:G-401 | 10809-111A8 |
21.22 | 3.82 |
| Wilms' tumor cell line:HFWT | 10597-108E3 |
14.08 | 5.28 |
| acantholytic squamous carcinoma cell line:HCC1806 | 10717-109I6 |
15.92 | 3.35 |
| achilles tendon, donor2 | 10292-104G4 |
8.27 | 0.00 |
| acute lymphoblastic leukemia (B-ALL) cell line:BALL-1 | 10455-106G5 |
17.59 | 3.57 |
| acute lymphoblastic leukemia (B-ALL) cell line:NALM-6 | 10534-107G3 |
9.05 | 1.86 |
| acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL | 10429-106D6 |
29.80 | 8.43 |
| acute lymphoblastic leukemia (T-ALL) cell line:Jurkat | 10464-106H5 |
25.85 | 9.80 |
| acute myeloid leukemia (FAB M0) cell line:KG-1 | 10827-111C8 |
12.65 | 3.65 |
| acute myeloid leukemia (FAB M0) cell line:Kasumi-3 | 10789-110H6 |
25.17 | 5.50 |
| acute myeloid leukemia (FAB M1) cell line:HYT-1 | 10828-111C9 |
13.88 | 1.09 |
| acute myeloid leukemia (FAB M2) cell line:Kasumi-1 | 10788-110H5 |
18.07 | 3.53 |
| acute myeloid leukemia (FAB M2) cell line:Kasumi-6 | 10792-110H9 |
60.44 | 14.29 |
| acute myeloid leukemia (FAB M2) cell line:NKM-1 | 10765-110E9 |
0.78 | 0.00 |
| acute myeloid leukemia (FAB M3) cell line:HL60 | 10829-111D1 |
8.28 | 2.39 |
| acute myeloid leukemia (FAB M4) cell line:FKH-1 | 10830-111D2 |
66.31 | 7.80 |
| acute myeloid leukemia (FAB M4) cell line:HNT-34 | 10831-111D3 |
5.34 | 3.02 |
| acute myeloid leukemia (FAB M4eo) cell line:EoL-1 | 10832-111D4 |
21.49 | 5.44 |
| acute myeloid leukemia (FAB M4eo) cell line:EoL-3 | 10833-111D5 |
20.16 | 4.68 |
| acute myeloid leukemia (FAB M5) cell line:NOMO-1 | 10764-110E8 |
15.34 | 0.46 |
| acute myeloid leukemia (FAB M5) cell line:P31/FUJ | 10770-110F5 |
13.98 | 2.47 |
| acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction) | 14298-155B5 |
6.14 | 3.99 |
| acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh) | 10399-106A3 |
6.40 | 1.28 |
| acute myeloid leukemia (FAB M5) cell line:THP-1 (revived) | 10400-106A4 |
6.67 | 3.34 |
| acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed) | 10405-106A9 |
6.98 | 1.20 |
| acute myeloid leukemia (FAB M5) cell line:U-937 DE-4 | 10834-111D6 |
28.29 | 3.79 |
| acute myeloid leukemia (FAB M6) cell line:EEB | 10835-111D7 |
75.38 | 8.67 |
| acute myeloid leukemia (FAB M6) cell line:F-36E | 10836-111D8 |
102.20 | 7.43 |
| acute myeloid leukemia (FAB M6) cell line:F-36P | 10837-111D9 |
94.54 | 11.30 |
| acute myeloid leukemia (FAB M7) cell line:M-MOK | 10699-109G6 |
27.91 | 7.41 |
| acute myeloid leukemia (FAB M7) cell line:MKPL-1 | 10802-111A1 |
26.24 | 1.87 |
| adenocarcinoma cell line:IM95m | 10796-110I4 |
24.73 | 4.95 |
| adipose tissue, adult, pool1 | 10010-101C1 |
16.29 | 2.79 |
| adipose, donor1 | 10184-103D4 |
28.15 | 4.10 |
| adipose, donor2 | 10185-103D5 |
32.85 | 11.35 |
| adipose, donor3 | 10186-103D6 |
29.41 | 10.62 |
| adipose, donor4 | 10187-103D7 |
26.87 | 6.93 |
| adrenal cortex adenocarcinoma cell line:SW-13 | 10810-111A9 |
30.14 | 9.94 |
| adrenal gland, adult, pool1 | 10081-102A9 |
32.74 | 7.28 |
| adult T-cell leukemia cell line:ATN-1 | 10421-106C7 |
23.75 | 3.60 |
| alveolar cell carcinoma cell line:SW 1573 | 10708-109H6 |
21.44 | 3.57 |
| amniotic membrane cells, donor1 | 12235-129G3 |
18.55 | 5.80 |
| amniotic membrane cells, donor2 | 12236-129G4 |
14.20 | 3.04 |
| amniotic membrane cells, donor3 | 12237-129G5 |
10.31 | 1.77 |
| amygdala - adult, donor10196 | 10167-103B5 |
5.93 | 4.74 |
| amygdala, adult, donor10252 | 10151-102I7 |
20.28 | 3.45 |
| amygdala, newborn, donor10223 | 10360-105E9 |
14.20 | 3.55 |
| anaplastic carcinoma cell line:8305C | 10428-106D5 |
26.10 | 4.58 |
| anaplastic large cell lymphoma cell line:Ki-JK | 10795-110I3 |
32.65 | 3.09 |
| anaplastic squamous cell carcinoma cell line:RPMI 2650 | 10805-111A4 |
32.07 | 8.02 |
| aorta, adult, pool1 | 10052-101G7 |
10.59 | 2.16 |
| appendix, adult | 10189-103D9 |
17.47 | 4.66 |
| argyrophil small cell carcinoma cell line:TC-YIK | 10589-108D4 |
41.62 | 9.97 |
| artery, adult | 10190-103E1 |
8.15 | 1.36 |
| astrocytoma cell line:TM-31 | 10425-106D2 |
31.58 | 5.07 |
| b cell line:RPMI1788 | 10427-106D4 |
18.44 | 2.68 |
| basal cell carcinoma cell line:TE 354.T | 10702-109G9 |
14.98 | 3.05 |
| bile duct carcinoma cell line:HuCCT1 | 10432-106D9 |
21.14 | 2.38 |
| bile duct carcinoma cell line:TFK-1 | 10496-107C1 |
20.92 | 1.51 |
| biphenotypic B myelomonocytic leukemia cell line:MV-4-11 | 10718-109I7 |
13.98 | 0.56 |
| bladder, adult, pool1 | 10011-101C2 |
10.43 | 2.17 |
| blood, adult, pool1 | 10053-101G8 |
6.64 | 0.00 |
| bone marrow stromal cell line:StromaNKtert | 10686-109F2 |
6.85 | 1.71 |
| bone marrow, adult | 10192-103E3 |
26.32 | 7.42 |
| brain, adult, donor1 | 10084-102B3 |
17.43 | 7.18 |
| brain, adult, pool1 | 10012-101C3 |
10.91 | 2.12 |
| brain, fetal, pool1 | 10085-102B4 |
16.03 | 5.34 |
| breast carcinoma cell line:MCF7 | 10482-107A5 |
9.58 | 2.64 |
| breast carcinoma cell line:MDA-MB-453 | 10419-106C5 |
18.47 | 2.87 |
| breast, adult, donor1 | 10080-102A8 |
18.31 | 3.79 |
| bronchial squamous cell carcinoma cell line:KNS-62 | 10760-110E4 |
20.45 | 6.35 |
| bronchioalveolar carcinoma cell line:NCI-H358 | 10709-109H7 |
8.66 | 2.47 |
| bronchioalveolar carcinoma cell line:NCI-H650 | 10715-109I4 |
22.33 | 7.83 |
| bronchogenic carcinoma cell line:ChaGo-K-1 | 10710-109H8 |
13.80 | 3.39 |
| carcinoid cell line:NCI-H1770 | 10703-109H1 |
15.99 | 4.70 |
| carcinoid cell line:NCI-H727 | 10735-110B6 |
9.63 | 2.30 |
| carcinoid cell line:SK-PN-DW | 10719-109I8 |
15.21 | 3.49 |
| carcinosarcoma cell line:JHUCS-1 | 10642-109A3 |
35.67 | 7.45 |
| caudate nucleus - adult, donor10196 | 10177-103C6 |
14.97 | 8.06 |
| caudate nucleus, adult, donor10252 | 10164-103B2 |
16.40 | 6.86 |
| caudate nucleus, adult, donor10258 | 10379-105H1 |
11.46 | 3.82 |
| caudate nucleus, newborn, donor10223 | 10354-105E3 |
22.34 | 5.86 |
| cerebellum - adult, donor10196 | 10173-103C2 |
37.87 | 8.74 |
| cerebellum, adult, donor10252 | 10166-103B4 |
38.65 | 5.76 |
| cerebellum, adult, pool1 | 10083-102B2 |
14.49 | 2.07 |
| cerebellum, newborn, donor10223 | 10357-105E6 |
27.40 | 3.32 |
| cerebral meninges, adult | 10188-103D8 |
11.09 | 4.54 |
| cerebrospinal fluid, donor2 | 10294-104G6 |
8.04 | 0.00 |
| cervical cancer cell line:D98-AH2 | 10552-107I3 |
25.59 | 3.31 |
| cervical cancer cell line:ME-180 | 10553-107I4 |
11.27 | 2.15 |
| cervix, adult, pool1 | 10013-101C4 |
17.43 | 3.46 |
| cholangiocellular carcinoma cell line:HuH-28 | 10536-107G5 |
20.90 | 3.20 |
| chondrosarcoma cell line:SW 1353 | 10700-109G7 |
6.53 | 1.31 |
| choriocarcinoma cell line:BeWo | 10423-106C9 |
31.57 | 8.08 |
| choriocarcinoma cell line:SCH | 10785-110H2 |
11.46 | 4.56 |
| choriocarcinoma cell line:T3M-3 | 10618-108G6 |
13.52 | 5.46 |
| chorionic membrane cells, donor1 | 12238-129G6 |
17.67 | 5.98 |
| chorionic membrane cells, donor2 | 12239-129G7 |
23.96 | 6.36 |
| chorionic membrane cells, donor3 | 12240-129G8 |
15.39 | 4.40 |
| chronic lymphocytic leukemia (T-CLL) cell line:SKW-3 | 10416-106C2 |
10.10 | 4.04 |
| chronic myeloblastic leukemia (CML) cell line:KCL-22 | 10801-110I9 |
11.53 | 3.84 |
| chronic myelogenous leukemia (CML) cell line:MEG-A2 | 10766-110F1 |
178.87 | 9.50 |
| chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1 | 10824-111C5 |
44.68 | 4.37 |
| chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2 | 10825-111C6 |
52.49 | 3.39 |
| chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3 | 10826-111C7 |
57.62 | 5.50 |
| chronic myelogenous leukemia cell line:K562 | 10454-106G4 |
69.20 | 5.30 |
| chronic myelogenous leukemia cell line:KU812 | 10409-106B4 |
193.12 | 12.77 |
| clear cell carcinoma cell line:JHOC-5 | 10638-108I8 |
12.34 | 1.83 |
| clear cell carcinoma cell line:TEN | 10636-108I6 |
19.78 | 5.03 |
| colon carcinoma cell line:CACO-2 | 10513-107D9 |
37.52 | 10.25 |
| colon carcinoma cell line:COLO-320 | 10420-106C6 |
26.61 | 4.18 |
| colon, adult, donor1 | 10082-102B1 |
19.04 | 4.76 |
| colon, adult, pool1 | 10014-101C5 |
26.91 | 4.23 |
| colon, fetal, donor1 | 10070-101I7 |
21.63 | 7.42 |
| common myeloid progenitor CMP, donor1 | 12130-128D6 |
55.00 | 4.58 |
| common myeloid progenitor CMP, donor2 | 12134-128E1 |
25.04 | 50.07 |
| cord blood derived cell line:COBL-a 24h infection(-C) | 10452-106G2 |
48.44 | 5.95 |
| cord blood derived cell line:COBL-a 24h infection | 10453-106G3 |
29.28 | 4.83 |
| cord blood derived cell line:COBL-a untreated | 10449-106F8 |
34.41 | 7.05 |
| corpus callosum, adult, pool1 | 10042-101F6 |
20.56 | 3.43 |
| cruciate ligament, donor2 | 10295-104G7 |
10.54 | 0.81 |
| diaphragm, fetal, donor1 | 10069-101I6 |
12.84 | 4.01 |
| diencephalon, adult | 10193-103E4 |
10.08 | 1.68 |
| diffuse large B-cell lymphoma cell line:CTB-1 | 10631-108I1 |
7.35 | 2.07 |
| ductal cell carcinoma cell line:KLM-1 | 10438-106E6 |
22.31 | 4.36 |
| ductal cell carcinoma cell line:MIA Paca2 | 10488-107B2 |
20.70 | 4.57 |
| ductus deferens, adult | 10196-103E7 |
22.92 | 5.48 |
| duodenum, fetal, donor1, tech_rep1 | 10071-101I8 |
38.89 | 12.96 |
| duodenum, fetal, donor1, tech_rep2 | 10071-101I8 |
36.05 | 4.41 |
| dura mater, adult, donor1 | 10041-101F5 |
15.77 | 2.97 |
| embryonic kidney cell line: HEK293/SLAM infection, 24hr | 10451-106G1 |
49.30 | 3.55 |
| embryonic kidney cell line: HEK293/SLAM untreated | 10450-106F9 |
56.17 | 8.17 |
| embryonic pancreas cell line:1B2C6 | 10604-108F1 |
10.48 | 1.23 |
| embryonic pancreas cell line:1C3D3 | 10605-108F2 |
15.14 | 4.24 |
| embryonic pancreas cell line:1C3IKEI | 10606-108F3 |
9.88 | 2.47 |
| embryonic pancreas cell line:2C6 | 10603-108E9 |
13.13 | 3.94 |
| endometrial carcinoma cell line:OMC-2 | 10497-107C2 |
64.36 | 6.70 |
| endometrial stromal sarcoma cell line:OMC-9 | 10448-106F7 |
21.75 | 5.44 |
| endometrioid adenocarcinoma cell line:JHUEM-1 | 10643-109A4 |
17.69 | 4.99 |
| epidermoid carcinoma cell line:A431 | 10426-106D3 |
12.56 | 3.67 |
| epidermoid carcinoma cell line:Ca Ski | 10431-106D8 |
23.76 | 3.63 |
| epididymis, adult | 10197-103E8 |
12.77 | 4.40 |
| epithelioid sarcoma cell line:HS-ES-1 | 10443-106F2 |
12.77 | 3.90 |
| epithelioid sarcoma cell line:HS-ES-2R | 10495-107B9 |
8.26 | 1.57 |
| epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1 | 10815-111B5 |
37.09 | 4.06 |
| epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2 | 10816-111B6 |
34.15 | 3.44 |
| epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3 | 10817-111B7 |
38.54 | 3.92 |
| esophagus, adult, pool1 | 10015-101C6 |
9.03 | 1.81 |
| extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS | 10410-106B5 |
38.07 | 12.15 |
| eye - muscle inferior rectus, donor1 | 10272-104E2 |
12.07 | 2.41 |
| eye - muscle lateral, donor2 | 10298-104H1 |
12.63 | 0.00 |
| eye - muscle medial, donor2 | 10299-104H2 |
7.44 | 0.00 |
| eye - muscle superior, donor2 | 10297-104G9 |
19.49 | 1.15 |
| eye - vitreous humor, donor1 | 10268-104D7 |
5.83 | 0.00 |
| eye, fetal, donor1 | 10054-101G9 |
22.37 | 5.34 |
| fibrosarcoma cell line:HT-1080 | 10758-110E2 |
24.49 | 4.74 |
| fibrous histiocytoma cell line:GCT TIB-223 | 10711-109H9 |
29.20 | 7.36 |
| frontal lobe, adult, pool1 | 10040-101F4 |
19.98 | 4.41 |
| gall bladder carcinoma cell line:TGBC14TKB | 10470-106I2 |
12.61 | 4.50 |
| gall bladder carcinoma cell line:TGBC2TKB | 10415-106C1 |
26.70 | 3.93 |
| gall bladder, adult | 10198-103E9 |
16.66 | 3.38 |
| gamma delta positive T cells, donor1 | 11937-126A2 |
16.11 | 5.37 |
| gamma delta positive T cells, donor2 | 11938-126A3 |
11.95 | 2.61 |
| gastric adenocarcinoma cell line:MKN1 | 10614-108G2 |
18.59 | 6.76 |
| gastric adenocarcinoma cell line:MKN45 | 10612-108F9 |
22.63 | 7.16 |
| gastric cancer cell line:AZ521 | 10549-107H9 |
32.79 | 4.26 |
| gastric cancer cell line:GSS | 10560-108A2 |
37.52 | 12.81 |
| gastrointestinal carcinoma cell line:ECC12 | 10615-108G3 |
53.00 | 8.91 |
| giant cell carcinoma cell line:LU65 | 10487-107B1 |
20.65 | 4.93 |
| giant cell carcinoma cell line:Lu99B | 10433-106E1 |
32.19 | 5.04 |
| glassy cell carcinoma cell line:HOKUG | 10688-109F4 |
25.69 | 4.99 |
| glioblastoma cell line:A172, tech_rep1 | 10444-106F3 |
19.74 | 3.91 |
| glioblastoma cell line:A172, tech_rep2 | 10444-106F3 |
18.40 | 3.51 |
| glioblastoma cell line:T98G | 10485-107A8 |
17.44 | 3.09 |
| glioma cell line:GI-1 | 10413-106B8 |
19.62 | 7.61 |
| globus pallidus - adult, donor10196 | 10175-103C4 |
8.02 | 2.19 |
| globus pallidus, adult, donor10252 | 10161-103A8 |
21.97 | 4.64 |
| globus pallidus, adult, donor10258 | 10367-105F7 |
8.22 | 4.11 |
| globus pallidus, newborn, donor10223 | 10364-105F4 |
21.32 | 3.73 |
| granulocyte macrophage progenitor, donor1 | 12131-128D7 |
4.89 | 2.45 |
| granulocyte macrophage progenitor, donor2 | 12135-128E2 |
0.00 | 0.00 |
| granulocyte macrophage progenitor, donor3 | 12139-128E6 |
15.68 | 0.00 |
| granulosa cell tumor cell line:KGN | 10624-108H3 |
15.68 | 5.12 |
| hIPS +CCl2, biol_rep1 | 14383-156B9 |
25.71 | 4.59 |
| hIPS +CCl2, biol_rep2 | 14384-156C1 |
32.92 | 7.32 |
| hIPS +CCl2, biol_rep3 | 14385-156C2 |
27.70 | 3.86 |
| hIPS, biol_rep1 | 14380-156B6 |
25.87 | 5.75 |
| hIPS, biol_rep2 | 14381-156B7 |
35.67 | 2.74 |
| hIPS, biol_rep3 | 14382-156B8 |
15.45 | 4.41 |
| hairy cell leukemia cell line:Mo | 10712-109I1 |
16.95 | 2.01 |
| heart - mitral valve, adult | 10205-103F7 |
12.56 | 4.19 |
| heart - pulmonic valve, adult | 10206-103F8 |
9.41 | 2.35 |
| heart - tricuspid valve, adult | 10207-103F9 |
12.49 | 3.33 |
| heart, adult, diseased post-infarction, donor1 | 10050-101G5 |
11.84 | 4.90 |
| heart, adult, diseased, donor1 | 10051-101G6 |
8.09 | 2.55 |
| heart, adult, pool1 | 10016-101C7 |
6.90 | 2.07 |
| heart, fetal, pool1 | 10046-101G1 |
23.41 | 4.42 |
| hepatic mesenchymal tumor cell line:LI90 | 10778-110G4 |
24.06 | 4.63 |
| hepatoblastoma cell line:HuH-6 | 10633-108I3 |
13.08 | 2.38 |
| hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1 | 10818-111B8 |
68.84 | 7.18 |
| hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2 | 10819-111B9 |
76.10 | 8.50 |
| hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3 | 10820-111C1 |
76.90 | 7.68 |
| hepatoma cell line:Li-7 | 10484-107A7 |
54.16 | 3.89 |
| hereditary spherocytic anemia cell line:WIL2-NS | 10808-111A7 |
29.45 | 4.22 |
| hippocampus - adult, donor10196 | 10169-103B7 |
7.57 | 3.79 |
| hippocampus, adult, donor10252 | 10153-102I9 |
17.14 | 4.69 |
| hippocampus, adult, donor10258 | 10374-105G5 |
18.42 | 4.98 |
| hippocampus, newborn, donor10223 | 10363-105F3 |
18.33 | 3.88 |
| iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1 | 13421-144D1 |
28.08 | 10.99 |
| iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2 | 13425-144D5 |
42.41 | 8.64 |
| iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3 | 13429-144D9 |
44.94 | 9.39 |
| iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1 | 13422-144D2 |
56.95 | 9.59 |
| iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2 | 13426-144D6 |
50.87 | 11.10 |
| iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3 | 13430-144E1 |
74.02 | 11.77 |
| iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1 | 13423-144D3 |
35.33 | 12.55 |
| iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2 | 13427-144D7 |
41.15 | 10.77 |
| iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3 | 13431-144E2 |
45.46 | 10.43 |
| iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1 | 13424-144D4 |
38.83 | 9.95 |
| iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2 | 13428-144D8 |
35.04 | 8.04 |
| iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3 | 13432-144E3 |
34.34 | 12.12 |
| iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1 | 13433-144E4 |
44.91 | 6.26 |
| iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2 | 13437-144E8 |
32.92 | 8.84 |
| iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3 | 13441-144F3 |
27.93 | 5.24 |
| iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1 | 13434-144E5 |
74.65 | 12.98 |
| iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2 | 13438-144E9 |
65.41 | 11.77 |
| iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3 | 13442-144F4 |
33.48 | 8.00 |
| iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1 | 13435-144E6 |
34.10 | 11.68 |
| iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2 | 13439-144F1 |
29.56 | 10.00 |
| iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3 | 13443-144F5 |
32.89 | 12.53 |
| iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1 | 13436-144E7 |
42.62 | 10.94 |
| iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2 | 13440-144F2 |
37.16 | 10.45 |
| iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3 | 13444-144F6 |
39.76 | 12.55 |
| iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1 | 13445-144F7 |
52.84 | 8.68 |
| iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2 | 13449-144G2 |
47.36 | 8.27 |
| iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3 | 13453-144G6 |
34.71 | 13.88 |
| iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1 | 13446-144F8 |
37.32 | 7.04 |
| iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2 | 13450-144G3 |
60.18 | 13.62 |
| iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3 | 13454-144G7 |
64.76 | 15.74 |
| iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1 | 13447-144F9 |
33.61 | 11.89 |
| iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2 | 13451-144G4 |
33.87 | 13.28 |
| iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3 | 13455-144G8 |
34.12 | 7.70 |
| iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1 | 13448-144G1 |
44.74 | 8.44 |
| iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2 | 13452-144G5 |
55.28 | 15.14 |
| iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3 | 13456-144G9 |
40.66 | 13.44 |
| iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1 | 13457-144H1 |
49.99 | 8.21 |
| iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2 | 13461-144H5 |
51.25 | 8.47 |
| iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3 | 13465-144H9 |
49.27 | 6.83 |
| iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1 | 13458-144H2 |
64.18 | 15.28 |
| iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2 | 13462-144H6 |
55.31 | 22.77 |
| iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3 | 13466-144I1 |
56.59 | 9.93 |
| iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1 | 13459-144H3 |
42.69 | 14.78 |
| iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2 | 13463-144H7 |
34.02 | 11.94 |
| iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3 | 13467-144I2 |
33.45 | 11.03 |
| iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1 | 13460-144H4 |
40.58 | 16.71 |
| iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2 | 13464-144H8 |
42.25 | 7.72 |
| iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3 | 13468-144I3 |
30.98 | 6.73 |
| immature langerhans cells, donor1 | 11904-125F5 |
2.66 | 1.45 |
| immature langerhans cells, donor2 | 11905-125F6 |
6.34 | 0.79 |
| insula, adult, pool1 | 10039-101F3 |
17.41 | 3.12 |
| keratoacanthoma cell line:HKA-1 | 10791-110H8 |
18.53 | 5.53 |
| kidney, adult, pool1 | 10017-101C8 |
34.64 | 5.81 |
| kidney, fetal, pool1 | 10045-101F9 |
27.16 | 6.22 |
| large cell lung carcinoma cell line:IA-LM | 10509-107D5 |
35.22 | 6.11 |
| large cell lung carcinoma cell line:NCI-H460 | 10839-111E2 |
29.72 | 9.12 |
| large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF | 10692-109F8 |
13.76 | 1.65 |
| left atrium, adult, donor1 | 10079-102A7 |
9.26 | 2.18 |
| left ventricle, adult, donor1 | 10078-102A6 |
11.12 | 0.51 |
| leiomyoblastoma cell line:G-402 | 10721-110A1 |
18.61 | 5.75 |
| leiomyoma cell line:10964C | 10569-108B2 |
18.32 | 3.23 |
| leiomyoma cell line:15242A | 10570-108B3 |
25.54 | 5.98 |
| leiomyoma cell line:15425 | 10571-108B4 |
20.64 | 5.58 |
| leiomyosarcoma cell line:Hs 5.T | 10722-110A2 |
6.35 | 0.00 |
| lens epithelial cell line:SRA 01/04 | 10647-109A8 |
33.46 | 5.23 |
| leukemia, chronic megakaryoblastic cell line:MEG-01 | 10752-110D5 |
128.68 | 7.67 |
| liposarcoma cell line:KMLS-1 | 10782-110G8 |
13.90 | 4.22 |
| liposarcoma cell line:SW 872 | 10726-110A6 |
29.61 | 2.68 |
| liver, adult, pool1 | 10018-101C9 |
38.41 | 6.97 |
| liver, fetal, pool1 | 10086-102B5 |
63.03 | 7.53 |
| locus coeruleus - adult, donor10196 | 10182-103D2 |
10.50 | 3.21 |
| locus coeruleus, adult, donor10252 | 10165-103B3 |
17.16 | 2.40 |
| locus coeruleus, adult, donor10258 | 10375-105G6 |
11.57 | 4.80 |
| locus coeruleus, newborn, donor10223 | 10362-105F2 |
9.67 | 3.36 |
| lung adenocarcinoma cell line:A549 | 10499-107C4 |
21.17 | 4.84 |
| lung adenocarcinoma cell line:PC-14 | 10408-106B3 |
9.65 | 4.14 |
| lung adenocarcinoma, papillary cell line:NCI-H441 | 10742-110C4 |
11.34 | 2.64 |
| lung, adult, pool1 | 10019-101D1 |
16.07 | 2.95 |
| lung, fetal, donor1 | 10068-101I5 |
65.93 | 9.70 |
| lung, right lower lobe, adult, donor1 | 10075-102A3 |
13.75 | 1.83 |
| lymph node, adult, donor1 | 10077-102A5 |
11.36 | 5.21 |
| lymphangiectasia cell line:DS-1 | 10727-110A7 |
22.14 | 3.95 |
| lymphoma, malignant, hairy B-cell cell line:MLMA | 10775-110G1 |
15.39 | 2.41 |
| malignant trichilemmal cyst cell line:DJM-1 | 10412-106B7 |
19.54 | 2.55 |
| mature adipocyte, donor1 | 12231-129F8 |
7.99 | 2.22 |
| mature adipocyte, donor2 | 12232-129F9 |
9.96 | 1.87 |
| mature adipocyte, donor3 | 12233-129G1 |
6.64 | 1.66 |
| mature adipocyte, donor4 | 12234-129G2 |
6.32 | 0.53 |
| maxillary sinus tumor cell line:HSQ-89 | 10414-106B9 |
18.11 | 3.10 |
| medial frontal gyrus - adult, donor10196 | 10170-103B8 |
12.41 | 2.26 |
| medial frontal gyrus, adult, donor10252 | 10150-102I6 |
23.17 | 2.76 |
| medial frontal gyrus, adult, donor10258 | 10368-105F8 |
12.71 | 1.59 |
| medial frontal gyrus, newborn, donor10223 | 10352-105E1 |
7.25 | 1.28 |
| medial temporal gyrus - adult, donor10196 | 10183-103D3 |
17.38 | 3.71 |
| medial temporal gyrus, adult, donor10252 | 10156-103A3 |
21.65 | 4.03 |
| medial temporal gyrus, adult, donor10258, tech_rep1 | 10376-105G7 |
5.78 | 7.71 |
| medial temporal gyrus, adult, donor10258, tech_rep2 | 10376-105G7 |
0.00 | 0.00 |
| medial temporal gyrus, newborn, donor10223 | 10353-105E2 |
15.08 | 3.23 |
| medulla oblongata - adult, donor10196 | 10174-103C3 |
9.09 | 3.24 |
| medulla oblongata, adult, donor10252 | 10155-103A2 |
19.20 | 4.95 |
| medulla oblongata, adult, pool1 | 10038-101F2 |
12.65 | 2.29 |
| medulla oblongata, newborn, donor10223 | 10361-105F1 |
19.44 | 3.82 |
| medulloblastoma cell line:D283 Med | 10838-111E1 |
41.63 | 7.75 |
| medulloblastoma cell line:ONS-76 | 10759-110E3 |
16.51 | 3.55 |
| melanoma cell line:COLO 679 | 10514-107E1 |
22.28 | 2.73 |
| melanoma cell line:G-361 | 10465-106H6 |
36.10 | 2.44 |
| meningioma cell line:HKBMM | 10691-109F7 |
21.71 | 5.97 |
| merkel cell carcinoma cell line:MKL-1 | 10843-111E6 |
25.55 | 7.05 |
| merkel cell carcinoma cell line:MS-1 | 10844-111E7 |
18.15 | 4.67 |
| mesenchymal precursor cell - adipose, donor1 | 11747-123G1 |
21.94 | 4.30 |
| mesenchymal precursor cell - adipose, donor2 | 11748-123G2 |
11.45 | 2.91 |
| mesenchymal precursor cell - adipose, donor3 | 11749-123G3 |
27.33 | 5.80 |
| mesenchymal precursor cell - bone marrow, donor1 | 11750-123G4 |
17.42 | 2.95 |
| mesenchymal precursor cell - bone marrow, donor2 | 11751-123G5 |
20.99 | 3.27 |
| mesenchymal precursor cell - bone marrow, donor3 | 11840-124H4 |
19.43 | 6.25 |
| mesenchymal precursor cell - cardiac, donor1 | 11752-123G6 |
25.06 | 4.46 |
| mesenchymal precursor cell - cardiac, donor2 | 11753-123G7 |
26.22 | 3.11 |
| mesenchymal precursor cell - cardiac, donor3 | 11754-123G8 |
27.59 | 4.91 |
| mesenchymal precursor cell - cardiac, donor4 | 11755-123G9 |
33.08 | 5.40 |
| mesenchymal precursor cell - ovarian cancer left ovary, donor1 | 11756-123H1 |
24.18 | 3.84 |
| mesenchymal precursor cell - ovarian cancer left ovary, donor2 | 11833-124G6 |
28.65 | 7.90 |
| mesenchymal precursor cell - ovarian cancer left ovary, donor3 | 11760-123H5 |
24.77 | 7.20 |
| mesenchymal precursor cell - ovarian cancer left ovary, donor4 | 11836-124G9 |
47.13 | 6.98 |
| mesenchymal precursor cell - ovarian cancer metastasis, donor1 | 11758-123H3 |
21.23 | 5.10 |
| mesenchymal precursor cell - ovarian cancer metastasis, donor2 | 11835-124G8 |
18.69 | 4.31 |
| mesenchymal precursor cell - ovarian cancer metastasis, donor3 | 11762-123H7 |
21.72 | 4.66 |
| mesenchymal precursor cell - ovarian cancer metastasis, donor4 | 11838-124H2 |
29.18 | 3.65 |
| mesenchymal precursor cell - ovarian cancer right ovary, donor1 | 11757-123H2 |
28.95 | 3.78 |
| mesenchymal precursor cell - ovarian cancer right ovary, donor2 | 11759-123H4 |
21.97 | 4.48 |
| mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02) | 11761-123H6 |
25.03 | 4.73 |
| mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G) | 11842-124H6 |
28.35 | 9.20 |
| mesenchymal precursor cell - ovarian cancer right ovary, donor4 | 11837-124H1 |
25.18 | 5.44 |
| mesenchymal stem cell line:Hu5/E18 | 10568-108B1 |
26.10 | 7.58 |
| mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1 | 13229-141I7 |
20.55 | 2.28 |
| mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2 | 13230-141I8 |
16.63 | 4.60 |
| mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3 | 13231-141I9 |
19.11 | 6.02 |
| mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1 | 13232-142A1 |
15.40 | 2.77 |
| mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2 | 13233-142A2 |
12.00 | 3.29 |
| mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3 | 13234-142A3 |
16.92 | 5.08 |
| mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1 | 13235-142A4 |
16.11 | 4.72 |
| mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2 | 13236-142A5 |
13.44 | 2.32 |
| mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3 | 13237-142A6 |
0.00 | 0.00 |
| mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1 | 13238-142A7 |
18.75 | 5.19 |
| mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2 | 13239-142A8 |
17.18 | 4.02 |
| mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3 | 13240-142A9 |
21.63 | 3.12 |
| mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1 | 13241-142B1 |
9.53 | 5.13 |
| mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2 | 13242-142B2 |
13.43 | 2.69 |
| mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3 | 13243-142B3 |
13.10 | 6.55 |
| mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1 | 13244-142B4 |
17.61 | 4.73 |
| mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2 | 13245-142B5 |
13.67 | 0.00 |
| mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3 | 13246-142B6 |
10.33 | 10.33 |
| mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1 | 13247-142B7 |
18.51 | 5.52 |
| mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2 | 13248-142B8 |
13.09 | 2.91 |
| mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3 | 13249-142B9 |
22.92 | 5.33 |
| mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1 | 13250-142C1 |
15.54 | 3.27 |
| mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2 | 13251-142C2 |
22.16 | 4.28 |
| mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3 | 13252-142C3 |
18.89 | 0.00 |
| mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1 | 13253-142C4 |
19.87 | 4.97 |
| mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2 | 13254-142C5 |
9.53 | 4.77 |
| mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3 | 13255-142C6 |
21.35 | 7.71 |
| mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1 | 13256-142C7 |
17.06 | 6.09 |
| mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2 | 13257-142C8 |
0.00 | 0.00 |
| mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3 | 13258-142C9 |
25.97 | 5.07 |
| mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1 | 13259-142D1 |
34.15 | 3.79 |
| mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2 | 13260-142D2 |
12.90 | 6.45 |
| mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3 | 13261-142D3 |
11.98 | 3.99 |
| mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1 | 13262-142D4 |
27.55 | 6.89 |
| mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2 | 13263-142D5 |
17.52 | 4.48 |
| mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3 | 13264-142D6 |
19.86 | 7.15 |
| mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1 | 13265-142D7 |
22.40 | 2.95 |
| mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2 | 13266-142D8 |
20.57 | 4.05 |
| mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3 | 13267-142D9 |
14.70 | 4.01 |
| mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1 | 13268-142E1 |
21.29 | 5.91 |
| mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2 | 13269-142E2 |
30.82 | 2.57 |
| mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3 | 13270-142E3 |
14.46 | 4.13 |
| mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1 | 13271-142E4 |
11.88 | 3.46 |
| mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2 | 13272-142E5 |
13.46 | 2.24 |
| mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3 | 13273-142E6 |
19.08 | 1.27 |
| mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1 | 13274-142E7 |
16.52 | 3.63 |
| mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2 | 13275-142E8 |
13.08 | 8.72 |
| mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3 | 13276-142E9 |
7.60 | 3.80 |
| mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1 | 13277-142F1 |
13.96 | 2.43 |
| mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2 | 13278-142F2 |
31.63 | 18.08 |
| mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3 | 13279-142F3 |
10.71 | 5.77 |
| mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1 | 13280-142F4 |
22.82 | 2.58 |
| mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2 | 13281-142F5 |
12.33 | 2.60 |
| mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3 | 13282-142F6 |
15.28 | 7.13 |
| mesodermal tumor cell line:HIRS-BM | 10696-109G3 |
3.09 | 0.77 |
| mesothelioma cell line:ACC-MESO-1 | 10493-107B7 |
13.70 | 2.13 |
| mesothelioma cell line:ACC-MESO-4 | 10494-107B8 |
43.32 | 6.02 |
| mesothelioma cell line:Mero-14, tech_rep1 | 10849-111F3 |
17.09 | 17.09 |
| mesothelioma cell line:Mero-14, tech_rep2 | 10849-111F3 |
15.82 | 1.95 |
| mesothelioma cell line:Mero-25 | 10850-111F4 |
19.97 | 2.72 |
| mesothelioma cell line:Mero-41 | 10851-111F5 |
27.14 | 4.65 |
| mesothelioma cell line:Mero-48a | 10852-111F6 |
17.27 | 2.44 |
| mesothelioma cell line:Mero-82 | 10853-111F7 |
24.70 | 2.63 |
| mesothelioma cell line:Mero-83 | 10854-111F8 |
27.07 | 2.38 |
| mesothelioma cell line:Mero-84 | 10855-111F9 |
36.90 | 4.55 |
| mesothelioma cell line:Mero-95 | 10856-111G1 |
75.78 | 8.07 |
| mesothelioma cell line:NCI-H2052 | 10847-111F1 |
41.08 | 5.80 |
| mesothelioma cell line:NCI-H226 | 10846-111E9 |
28.96 | 3.80 |
| mesothelioma cell line:NCI-H2452 | 10848-111F2 |
19.30 | 4.27 |
| mesothelioma cell line:NCI-H28 | 10845-111E8 |
17.81 | 7.38 |
| mesothelioma cell line:No36 | 10857-111G2 |
27.07 | 4.57 |
| mesothelioma cell line:ONE58 | 10858-111G3 |
49.31 | 7.04 |
| migratory langerhans cells, donor1 | 11901-125F2 |
6.91 | 3.45 |
| migratory langerhans cells, donor2 | 11902-125F3 |
5.86 | 2.32 |
| migratory langerhans cells, donor3 | 11903-125F4 |
13.10 | 4.49 |
| mixed mullerian tumor cell line:HTMMT | 10689-109F5 |
28.73 | 3.59 |
| mucinous adenocarcinoma cell line:JHOM-1 | 10648-109A9 |
15.47 | 2.97 |
| mucinous cystadenocarcinoma cell line:MCAS | 10784-110H1 |
15.66 | 2.07 |
| mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162 | 10744-110C6 |
23.98 | 5.52 |
| myelodysplastic syndrome cell line:SKM-1 | 10772-110F7 |
6.65 | 1.11 |
| myeloma cell line:PCM6 | 10474-106I6 |
18.98 | 2.37 |
| myxofibrosarcoma cell line:MFH-ino | 10600-108E6 |
23.84 | 1.52 |
| myxofibrosarcoma cell line:NMFH-1 | 10684-109E9 |
19.61 | 5.49 |
| nasal epithelial cells, donor1, tech_rep1 | 12226-129F3 |
17.83 | 3.45 |
| nasal epithelial cells, donor1, tech_rep2 | 12226-129F3 |
17.80 | 3.90 |
| nasal epithelial cells, donor2 | 12227-129F4 |
2.76 | 2.76 |
| neuroblastoma cell line:CHP-134 | 10508-107D4 |
21.86 | 4.60 |
| neuroblastoma cell line:NB-1 | 10539-107G8 |
71.28 | 8.61 |
| neuroblastoma cell line:NBsusSR | 10607-108F4 |
26.78 | 7.38 |
| neuroblastoma cell line:NH-12 | 10555-107I6 |
46.59 | 7.83 |
| neuroectodermal tumor cell line:FU-RPNT-1 | 10637-108I7 |
37.24 | 15.89 |
| neuroectodermal tumor cell line:FU-RPNT-2 | 10663-109C6 |
16.79 | 7.44 |
| neuroectodermal tumor cell line:TASK1 | 10774-110F9 |
19.72 | 3.42 |
| neuroepithelioma cell line:SK-N-MC | 10728-110A8 |
3.18 | 2.54 |
| neurofibroma cell line:Hs 53.T | 10729-110A9 |
14.11 | 1.33 |
| neutrophil PMN, donor1 | 12133-128D9 |
0.00 | 0.00 |
| neutrophil PMN, donor2 | 12137-128E4 |
0.00 | 0.00 |
| neutrophil PMN, donor3 | 12141-128E8 |
0.00 | 0.00 |
| non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK | 10430-106D7 |
46.51 | 7.44 |
| non-small cell lung cancer cell line:NCI-H1385 | 10730-110B1 |
17.61 | 1.60 |
| normal embryonic palatal mesenchymal cell line:HEPM | 10813-111B3 |
19.24 | 6.41 |
| normal intestinal epithelial cell line:FHs 74 Int | 10812-111B2 |
85.40 | 7.88 |
| nucleus accumbens, adult, pool1 | 10037-101F1 |
16.50 | 3.84 |
| occipital cortex - adult, donor10196 | 10172-103C1 |
24.72 | 2.06 |
| occipital cortex, adult, donor10252 | 10163-103B1 |
24.69 | 5.64 |
| occipital cortex, newborn, donor10223 | 10355-105E4 |
13.83 | 3.28 |
| occipital lobe, adult, donor1 | 10076-102A4 |
15.74 | 4.20 |
| occipital lobe, fetal, donor1 | 10073-102A1 |
48.92 | 13.30 |
| occipital pole, adult, pool1 | 10036-101E9 |
11.43 | 2.13 |
| olfactory region, adult | 10195-103E6 |
11.27 | 2.87 |
| optic nerve, donor1 | 10277-104E7 |
32.02 | 0.00 |
| oral squamous cell carcinoma cell line:Ca9-22 | 10434-106E2 |
29.62 | 6.72 |
| oral squamous cell carcinoma cell line:HO-1-u-1 | 10550-107I1 |
27.89 | 4.95 |
| oral squamous cell carcinoma cell line:HSC-3 | 10545-107H5 |
19.13 | 6.10 |
| oral squamous cell carcinoma cell line:SAS | 10544-107H4 |
16.06 | 2.89 |
| osteoclastoma cell line:Hs 706.T | 10704-109H2 |
21.46 | 4.41 |
| osteosarcoma cell line:143B/TK^(-)neo^(R) | 10510-107D6 |
7.47 | 1.87 |
| osteosarcoma cell line:HS-Os-1 | 10558-107I9 |
23.54 | 4.24 |
| ovary, adult, pool1 | 10020-101D2 |
14.06 | 3.23 |
| pagetoid sarcoma cell line:Hs 925.T | 10732-110B3 |
13.57 | 2.02 |
| pancreas, adult, donor1 | 10049-101G4 |
24.46 | 9.41 |
| pancreatic carcinoma cell line:NOR-P1 | 10698-109G5 |
8.11 | 1.96 |
| papillary adenocarcinoma cell line:8505C | 10437-106E5 |
21.29 | 5.62 |
| papillotubular adenocarcinoma cell line:TGBC18TKB | 10417-106C3 |
13.25 | 1.99 |
| paracentral gyrus, adult, pool1 | 10035-101E8 |
18.03 | 3.20 |
| parietal cortex, adult, donor10258 | 10373-105G4 |
11.01 | 4.40 |
| parietal lobe - adult, donor10196 | 10171-103B9 |
15.05 | 2.82 |
| parietal lobe, adult, donor10252 | 10157-103A4 |
20.52 | 5.13 |
| parietal lobe, adult, pool1 | 10034-101E7 |
16.04 | 2.38 |
| parietal lobe, fetal, donor1 | 10072-101I9 |
36.85 | 9.70 |
| parietal lobe, newborn, donor10223 | 10356-105E5 |
13.09 | 4.86 |
| parotid gland, adult | 10199-103F1 |
9.25 | 2.47 |
| penis, adult | 10200-103F2 |
10.21 | 3.22 |
| peripheral neuroectodermal tumor cell line:KU-SN | 10697-109G4 |
12.64 | 5.58 |
| pharyngeal carcinoma cell line:Detroit 562 | 10723-110A3 |
15.74 | 3.64 |
| pineal gland - adult, donor10196 | 10179-103C8 |
17.42 | 0.65 |
| pineal gland, adult, donor10252 | 10160-103A7 |
30.20 | 10.07 |
| pineal gland, adult, donor10258 | 10377-105G8 |
19.44 | 6.90 |
| pituitary gland - adult, donor10196 | 10180-103C9 |
33.39 | 10.12 |
| pituitary gland, adult, donor10252 | 10162-103A9 |
64.63 | 11.47 |
| pituitary gland, adult, donor10258 | 10378-105G9 |
33.20 | 8.51 |
| placenta, adult, pool1 | 10021-101D3 |
48.48 | 10.32 |
| plasma cell leukemia cell line:ARH-77 | 10840-111E3 |
28.21 | 5.56 |
| pleomorphic hepatocellular carcinoma cell line:SNU-387 | 10706-109H4 |
17.43 | 3.42 |
| pons, adult, pool1 | 10033-101E6 |
13.68 | 1.38 |
| postcentral gyrus, adult, pool1 | 10032-101E5 |
13.60 | 2.96 |
| promyelocytes/myelocytes PMC, donor1 | 12132-128D8 |
8.37 | 0.00 |
| promyelocytes/myelocytes PMC, donor2 | 12136-128E3 |
16.52 | 5.51 |
| promyelocytes/myelocytes PMC, donor3 | 12140-128E7 |
0.00 | 0.00 |
| prostate cancer cell line:DU145 | 10490-107B4 |
35.10 | 5.68 |
| prostate cancer cell line:PC-3 | 10439-106E7 |
24.87 | 2.18 |
| prostate, adult, pool1 | 10022-101D4 |
17.41 | 3.26 |
| putamen, adult, donor10196 | 10176-103C5 |
12.28 | 5.43 |
| putamen, adult, donor10252 | 10152-102I8 |
15.69 | 3.92 |
| putamen, adult, donor10258, tech_rep1 | 10372-105G3 |
9.84 | 8.74 |
| putamen, adult, donor10258, tech_rep2 | 10372-105G3 |
12.81 | 7.01 |
| putamen, newborn, donor10223 | 10365-105F5 |
9.00 | 0.75 |
| rectal cancer cell line:TT1TKB | 10469-106I1 |
7.56 | 1.16 |
| rectum, fetal, donor1 | 10067-101I4 |
41.73 | 11.13 |
| renal cell carcinoma cell line:OS-RC-2 | 10411-106B6 |
20.14 | 5.94 |
| renal cell carcinoma cell line:TUHR10TKB | 10471-106I3 |
23.20 | 2.90 |
| retina, adult, pool1 | 10030-101E3 |
19.78 | 5.17 |
| retinoblastoma cell line:Y79 | 10475-106I7 |
29.88 | 5.98 |
| rhabdomyosarcoma cell line:KYM-1 | 10787-110H4 |
26.80 | 4.79 |
| rhabdomyosarcoma cell line:RMS-YM | 10477-106I9 |
14.34 | 1.12 |
| sacrococcigeal teratoma cell line:HTST | 10695-109G2 |
21.22 | 2.27 |
| salivary acinar cells, donor1 | 11771-123I7 |
17.32 | 3.40 |
| salivary acinar cells, donor2 | 11772-123I8 |
15.83 | 4.82 |
| salivary acinar cells, donor3 | 11773-123I9 |
9.27 | 2.65 |
| salivary gland, adult, pool1 | 10093-102C3 |
15.44 | 1.72 |
| schwannoma cell line:HS-PSS, tech_rep1 | 10442-106F1 |
17.62 | 4.81 |
| schwannoma cell line:HS-PSS, tech_rep2 | 10442-106F1 |
12.58 | 3.29 |
| seminal vesicle, adult | 10201-103F3 |
23.81 | 3.17 |
| serous adenocarcinoma cell line:JHOS-2 | 10639-108I9 |
14.09 | 3.40 |
| serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1 | 11843-124H7 |
16.10 | 3.02 |
| serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1 | 11841-124H5 |
16.06 | 4.01 |
| serous cystadenocarcinoma cell line:HTOA | 10693-109F9 |
29.28 | 5.78 |
| signet ring carcinoma cell line:Kato III | 10436-106E4 |
12.60 | 2.76 |
| signet ring carcinoma cell line:NUGC-4 | 10483-107A6 |
18.45 | 2.32 |
| skeletal muscle - soleus muscle, donor1 | 10282-104F3 |
7.09 | 0.71 |
| skeletal muscle, adult, pool1 | 10023-101D5 |
7.80 | 1.92 |
| skeletal muscle, fetal, donor1 | 10066-101I3 |
15.08 | 2.01 |
| skin, adult, donor1 | 10074-102A2 |
13.57 | 0.00 |
| skin, fetal, donor1 | 10065-101I2 |
18.94 | 4.42 |
| small cell cervical cancer cell line:HCSC-1 | 10800-110I8 |
51.03 | 5.00 |
| small cell gastrointestinal carcinoma cell line:ECC10 | 10610-108F7 |
40.66 | 11.66 |
| small cell lung carcinoma cell line:DMS 144 | 10841-111E4 |
40.67 | 11.76 |
| small cell lung carcinoma cell line:LK-2 | 10541-107H1 |
18.30 | 2.31 |
| small cell lung carcinoma cell line:NCI-H82 | 10842-111E5 |
26.06 | 3.22 |
| small cell lung carcinoma cell line:WA-hT | 10562-108A4 |
19.61 | 4.14 |
| small intestine, adult, pool1 | 10024-101D6 |
41.81 | 7.88 |
| small intestine, fetal, donor1 | 10064-101I1 |
34.40 | 5.90 |
| small-cell gastrointestinal carcinoma cell line:ECC4 | 10609-108F6 |
15.90 | 3.08 |
| smooth muscle, adult, pool1 | 10048-101G3 |
9.82 | 1.55 |
| somatostatinoma cell line:QGP-1 | 10781-110G7 |
24.93 | 6.43 |
| spinal cord - adult, donor10196 | 10181-103D1 |
10.78 | 0.92 |
| spinal cord, adult, donor10252 | 10159-103A6 |
12.22 | 0.79 |
| spinal cord, adult, donor10258 | 10369-105F9 |
6.23 | 2.77 |
| spinal cord, fetal, donor1 | 10056-101H2 |
21.95 | 6.10 |
| spinal cord, newborn, donor10223 | 10359-105E8 |
10.10 | 3.67 |
| spindle cell sarcoma cell line:Hs 132.T | 10737-110B8 |
15.23 | 2.84 |
| spleen, adult, pool1 | 10025-101D7 |
12.00 | 2.31 |
| spleen, fetal, pool1 | 10044-101F8 |
24.15 | 4.37 |
| splenic lymphoma with villous lymphocytes cell line:SLVL | 10424-106D1 |
39.23 | 7.45 |
| squamous cell carcinoma cell line:EC-GI-10 | 10463-106H4 |
16.14 | 2.85 |
| squamous cell carcinoma cell line:JHUS-nk1 | 10646-109A7 |
26.21 | 5.94 |
| squamous cell carcinoma cell line:T3M-5 | 10616-108G4 |
14.07 | 3.52 |
| squamous cell lung carcinoma cell line:EBC-1 | 10486-107A9 |
15.31 | 3.49 |
| squamous cell lung carcinoma cell line:LC-1F | 10457-106G7 |
19.06 | 5.08 |
| squamous cell lung carcinoma cell line:RERF-LC-AI | 10501-107C6 |
16.92 | 3.81 |
| stomach, fetal, donor1 | 10062-101H8 |
10.68 | 2.14 |
| submaxillary gland, adult | 10202-103F4 |
19.37 | 4.56 |
| substantia nigra - adult, donor10196 | 10178-103C7 |
54.27 | 0.00 |
| substantia nigra, adult, donor10252 | 10158-103A5 |
18.69 | 3.12 |
| substantia nigra, adult, donor10258 | 10371-105G2 |
12.93 | 2.07 |
| substantia nigra, newborn, donor10223 | 10358-105E7 |
23.32 | 4.95 |
| synovial sarcoma cell line:HS-SY-II | 10441-106E9 |
36.68 | 6.65 |
| temporal lobe, adult, pool1 | 10031-101E4 |
10.51 | 2.63 |
| temporal lobe, fetal, donor1, tech_rep1 | 10063-101H9 |
30.63 | 13.53 |
| temporal lobe, fetal, donor1, tech_rep2 | 10063-101H9 |
34.72 | 12.75 |
| tenocyte, donor1 | 11763-123H8 |
22.69 | 6.63 |
| tenocyte, donor2 | 11765-123I1 |
25.18 | 3.05 |
| tenocyte, donor3 | 11768-123I4 |
27.43 | 6.30 |
| teratocarcinoma cell line:NCC-IT-A3 | 10790-110H7 |
23.45 | 6.12 |
| teratocarcinoma cell line:NCR-G1 | 10798-110I6 |
38.07 | 6.47 |
| teratocarcinoma cell line:PA-1 | 10807-111A6 |
30.38 | 3.72 |
| testicular germ cell embryonal carcinoma cell line:ITO-II | 10786-110H3 |
14.98 | 3.17 |
| testicular germ cell embryonal carcinoma cell line:NEC14 | 10591-108D6 |
32.52 | 7.19 |
| testicular germ cell embryonal carcinoma cell line:NEC15 | 10593-108D8 |
14.72 | 1.64 |
| testicular germ cell embryonal carcinoma cell line:NEC8 | 10590-108D5 |
4.56 | 2.93 |
| testis, adult, pool1 | 10026-101D8 |
18.79 | 4.19 |
| testis, adult, pool2 | 10096-102C6 |
20.75 | 9.92 |
| thalamus - adult, donor10196 | 10168-103B6 |
5.52 | 2.21 |
| thalamus, adult, donor10252 | 10154-103A1 |
21.10 | 2.97 |
| thalamus, adult, donor10258, tech_rep1 | 10370-105G1 |
1.54 | 3.08 |
| thalamus, adult, donor10258, tech_rep2 | 10370-105G1 |
7.91 | 3.29 |
| thalamus, newborn, donor10223 | 10366-105F6 |
9.78 | 1.15 |
| throat, adult | 10209-103G2 |
14.98 | 3.75 |
| throat, fetal, donor1 | 10061-101H7 |
12.80 | 7.01 |
| thymic carcinoma cell line:Ty-82 | 10803-111A2 |
13.91 | 3.38 |
| thymus, adult, pool1 | 10027-101D9 |
20.28 | 9.64 |
| thymus, fetal, pool1 | 10043-101F7 |
25.87 | 6.55 |
| thyroid carcinoma cell line:KHM-5M | 10776-110G2 |
13.16 | 3.06 |
| thyroid carcinoma cell line:TCO-1 | 10783-110G9 |
21.79 | 3.77 |
| thyroid, adult, pool1 | 10028-101E1 |
24.63 | 6.16 |
| thyroid, fetal, donor1 | 10060-101H6 |
21.09 | 7.12 |
| tongue epidermis (fungiform papillae), donor1 | 10288-104F9 |
6.16 | 3.08 |
| tongue, adult | 10203-103F5 |
7.68 | 2.56 |
| tongue, fetal, donor1 | 10059-101H5 |
12.61 | 1.58 |
| tonsil, adult, pool1 | 10047-101G2 |
13.62 | 3.41 |
| trachea, adult, pool1 | 10029-101E2 |
16.44 | 4.01 |
| trachea, fetal, donor1 | 10058-101H4 |
15.00 | 3.46 |
| transitional cell carcinoma cell line:Hs 769.T | 10707-109H5 |
20.90 | 6.02 |
| transitional-cell carcinoma cell line:5637 | 10418-106C4 |
20.47 | 3.34 |
| transitional-cell carcinoma cell line:JMSU1 | 10492-107B6 |
35.10 | 6.74 |
| tridermal teratoma cell line:HGRT | 10694-109G1 |
15.22 | 1.90 |
| tubular adenocarcinoma cell line:SUIT-2 | 10797-110I5 |
30.30 | 5.76 |
| umbilical cord, fetal, donor1 | 10057-101H3 |
12.52 | 4.17 |
| uterus, adult, pool1 | 10100-102D1 |
28.49 | 3.75 |
| uterus, fetal, donor1 | 10055-101H1 |
17.41 | 2.56 |
| vagina, adult | 10204-103F6 |
21.97 | 3.23 |
| vein, adult | 10191-103E2 |
13.15 | 2.85 |
| xeroderma pigentosum b cell line:XPL 17 | 10563-108A5 |
5.34 | 2.14 |